UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

[X]	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
	SECURITIES EXCHANGE ACT OF 1934
	For the quarterly period ended September 2, 2017
OR
[  ]	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
	SECURITIES EXCHANGE ACT OF 1934
	For the transition period from                            to

Commission file number: 001-09225

H.B. FULLER COMPANY

(Exact name of registrant as specified in its charter)

Minnesota	41-0268370
(State or other jurisdiction of	(I.R.S. Employer
incorporation or organization)	Identification No.)
1200 Willow Lake Boulevard, St. Paul, Minnesota	55110-5101
(Address of principal executive offices)	(Zip Code)

(651) 236-5900

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [  ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [X] No [  ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer [X]	Accelerated filer [  ]
Non-accelerated filer [  ] (Do not check if a smaller reporting company)	Smaller reporting company [  ]
	Emerging growth company [  ]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  [  ]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).

Yes [  ] No [X]

The number of shares outstanding of the Registrant’s Common Stock, par value $1.00 per share, was 50,332,826 as of September 22, 2017.

1

H.B. Fuller Company

Quarterly Report on Form 10-Q

Table of Contents

		Page
PART 1. FINANCIAL INFORMATION
ITEM 1.	FINANCIAL STATEMENTS (Unaudited)	3
	Condensed Consolidated Statements of Income for the three and nine months ended September 2, 2017 and August 27, 2016	3
	Condensed Consolidated Statements of Comprehensive Income for the three and nine months ended September 2, 2017 and August 27, 2016	4
	Condensed Consolidated Balance Sheets as of September 2, 2017 and December 3, 2016	5
	Condensed Consolidated Statements of Total Equity as of September 2, 2017 and December 3, 2016	6
	Condensed Consolidated Statements of Cash Flows for the nine months ended September 2, 2017 and August 27, 2016	7
	Notes to Condensed Consolidated Financial Statements	8
ITEM 2.	MANAGEMENT DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	29
ITEM 3.	QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK	41
ITEM 4.	CONTROLS AND PROCEDURES	43
PART II. OTHER INFORMATION
ITEM 1.	LEGAL PROCEEDINGS	43
ITEM 1A.	RISK FACTORS	44
ITEM 2.	UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS	47
ITEM 6.	EXHIBITS	48
SIGNATURES		49

2

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

H.B. FULLER COMPANY AND SUBSIDIARIES

Condensed Consolidated Statements of Income

(In thousands, except per share amounts)

(Unaudited)

	Three Months Ended						Nine Months Ended
	September 2,			August 27,			September 2,			August 27,
	2017			2016			2017			2016
Net revenue	$	562,869		$	512,858		$	1,627,843		$	1,519,698
Cost of sales		(412,469	)		(366,737	)		(1,192,409	)		(1,077,716	)
Gross profit		150,400			146,121			435,434			441,982
Selling, general and administrative expenses		(110,219	)		(97,692	)		(325,904	)		(301,143	)
Special charges, net		-			2,807			-			2,024
Other income (expense), net		150			(956	)		661			(7,603	)
Interest expense		(8,100	)		(6,809	)		(24,628	)		(19,714	)
Income before income taxes and income from equity method investments		32,231			43,471			85,563			115,546
Income taxes		(9,262	)		(12,513	)		(26,178	)		(35,563	)
Income from equity method investments, net of tax		2,170			1,840			6,449			5,172
Net income including non-controlling interests		25,139			32,798			65,834			85,155
Net income attributable to non-controlling interests		(1	)		(53	)		(34	)		(161	)
Net income attributable to H.B. Fuller	$	25,138		$	32,745		$	65,800		$	84,994
Earnings per share attributable to H.B. Fuller common stockholders:
Basic		0.50			0.65			1.31			1.70
Diluted		0.49			0.64			1.28			1.66
Weighted-average common shares outstanding:
Basic		50,384			50,261			50,374			50,122
Diluted		51,605			51,453			51,584			51,234
Dividends declared per common share	$	0.15		$	0.14		$	0.44		$	0.41

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements.

3

H.B. FULLER COMPANY AND SUBSIDIARIES

Condensed Consolidated Statements of Comprehensive Income

(In thousands)

(Unaudited)

	Three Months Ended					Nine Months Ended
	September 2,			August 27,		September 2,		August 27,
	2017			2016		2017		2016
Net income including non-controlling interests	$	25,139		$	32,798	$	65,834	$	85,155
Other comprehensive income
Foreign currency translation		29,090			3,368		37,084		3,860
Defined benefit pension plans adjustment, net of tax		1,627			1,677		4,810		5,032
Interest rate swaps, net of tax		10			10		30		30
Cash-flow hedges, net of tax		(99	)		35		7		(156	)
Other comprehensive income		30,628			5,090		41,931		8,766
Comprehensive income		55,767			37,888		107,765		93,921
Less: Comprehensive (loss) income attributable to non-controlling interests		(11	)		53		23		161
Comprehensive income attributable to H.B. Fuller	$	55,778		$	37,835	$	107,742	$	93,760

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements.

4

H.B. FULLER COMPANY AND SUBSIDIARIES

Condensed Consolidated Balance Sheets

(In thousands, except share and per share amounts)

	(Unaudited)
	September 2,			December 3,
	2017			2016
Assets
Current assets:
Cash and cash equivalents	$	119,595		$	142,245
Trade receivables (net of allowances of $12,214 and $12,310, as of September 2,2017 and December 3, 2016, respectively)		393,054			351,130
Inventories		317,968			247,399
Other current assets		86,294			70,479
Total current assets		916,911			811,253
Property, plant and equipment		1,136,083			1,093,141
Accumulated depreciation		(609,262	)		(577,866	)
Property, plant and equipment, net		526,821			515,275
Goodwill		444,642			366,248
Other intangibles, net		238,484			205,359
Other assets		161,465			157,733
Total assets	$	2,288,323		$	2,055,868
Liabilities, redeemable non-controlling interest and total equity
Current liabilities:
Notes payable	$	28,392		$	37,334
Current maturities of long-term debt		10,000			80,178
Trade payables		193,345			162,964
Accrued compensation		59,306			52,444
Income taxes payable		10,301			7,985
Other accrued expenses		47,621			50,939
Total current liabilities		348,965			391,844
Long-term debt, excluding current maturities		760,581			585,759
Accrued pension liabilities		67,815			73,545
Other liabilities		78,426			62,174
Total liabilities		1,255,787			1,113,322
Commitments and contingencies (Note 16)
Redeemable non-controlling interest		-			4,277
Equity:
H.B. Fuller stockholders' equity:
Preferred stock (no shares outstanding) shares authorized – 10,045,900		-			-
Common stock, par value $1.00 per share, shares authorized – 160,000,000, shares outstanding – 50,297,998 and 50,141,343, as of September 2, 2017 and December 3, 2016, respectively		50,298			50,141
Additional paid-in capital		68,237			59,564
Retained earnings		1,134,411			1,090,900
Accumulated other comprehensive loss		(220,787	)		(262,729	)
Total H.B. Fuller stockholders' equity		1,032,159			937,876
Non-controlling interests		377			393
Total equity		1,032,536			938,269
Total liabilities, redeemable non-controlling interest and total equity	$	2,288,323		$	2,055,868

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements.

5

H.B. FULLER COMPANY AND SUBSIDIARIES

Condensed Consolidated Statements of Total Equity

(In thousands)

(Unaudited)

	H.B. Fuller Company Shareholders
	Common Stock			Additional Paid-in Capital			Retained Earnings			Accumulated Other Comprehensive Income (Loss)			Non-Controlling Interests			Total
Balance at November 28, 2015	$	50,074		$	55,522		$	994,608		$	(227,284	)	$	406		$	873,326
Comprehensive income (loss)		-			-			124,128			(35,445	)		226			88,909
Dividends		-			-			(27,836	)		-			-			(27,836	)
Stock option exercises		519			10,750			-			-			-			11,269
Share-based compensation plans other, net		116			14,485			-			-			-			14,601
Tax benefit on share-based compensation plans		-			1,467			-			-			-			1,467
Repurchases of common stock		(568	)		(22,660	)		-			-			-			(23,228	)
Redeemable non-controlling interest		-			-			-			-			(239	)		(239	)
Balance at December 3, 2016		50,141			59,564			1,090,900			(262,729	)		393			938,269
Comprehensive income		-			-			65,800			41,942			23			107,765
Dividends		-			-			(22,289	)		-			-			(22,289	)
Stock option exercises		438			14,595			-			-			-			15,033
Share-based compensation plans other, net		148			13,768			-			-			-			13,916
Tax benefit on share-based compensation plans		-			1,504			-			-			-			1,504
Repurchases of common stock		(429	)		(21,288	)		-			-			-			(21,717	)
Purchase of redeemable non-controlling interest		-			94			-			-			-			94
Redeemable non-controlling interest		-			-			-			-			(39	)		(39	)
Balance at September 2, 2017	$	50,298		$	68,237		$	1,134,411		$	(220,787	)	$	377		$	1,032,536

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements.

6

H.B. FULLER COMPANY AND SUBSIDIARIES

Condensed Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)

	Nine Months Ended
	September 2, 2017			August 27, 2016
Cash flows from operating activities:
Net income including non-controlling interests	$	65,834		$	85,155
Adjustments to reconcile net income including non-controlling interests to net cash provided by operating activities:
Depreciation		36,375			36,730
Amortization		23,128			20,509
Deferred income taxes		1,660			3,785
Income from equity method investments, net of dividends received		(2,639	)		(5,172	)
Gain on sale of assets		(149	)		(2,794	)
Share-based compensation		12,034			9,469
Excess tax benefit from share-based compensation		(1,504	)		(1,462	)
Gain on mark to market adjustment to contingent consideration liability		(2,453	)		(801	)
Non-cash charge for sale of inventories revalued at acquisition		193			528
Change in assets and liabilities, net of effects of acquisitions:
Trade receivables, net		(14,016	)		25,646
Inventories		(55,339	)		(6,165	)
Other assets		2,460			1,790
Trade payables		23,022			(1,365	)
Accrued compensation		3,881			(6,715	)
Other accrued expenses		(5,755	)		(4,858	)
Income taxes payable		(7,252	)		(1,415	)
Accrued / prepaid pensions		(3,969	)		(2,072	)
Other liabilities		12,639			(9,088	)
Other		(17,345	)		4,199
Net cash provided by operating activities		70,805			145,904
Cash flows from investing activities:
Purchased property, plant and equipment		(35,511	)		(49,569	)
Purchased businesses, net of cash acquired		(123,305	)		(51,298	)
Purchased investments		(1,250	)		-
Proceeds from sale of property, plant and equipment		745			4,403
Net cash used in investing activities		(159,321	)		(96,464	)
Cash flows from financing activities:
Proceeds from issuance of long-term debt		643,000			-
Repayment of long-term debt and payment of debt issuance costs		(540,524	)		(16,875	)
Net (payment of) proceeds from notes payable		(10,921	)		6,639
Dividends paid		(22,058	)		(20,570	)
Purchase of redeemable non-controlling interest		(3,127	)		-
Proceeds from stock options exercised		15,033			9,760
Excess tax benefit from share-based compensation		1,504			1,462
Repurchases of common stock		(21,717	)		(11,901	)
Net cash provided by (used in) financing activities		61,190			(31,485	)
Effect of exchange rate changes on cash and cash equivalents		4,676			(4,021	)
Net change in cash and cash equivalents		(22,650	)		13,934
Cash and cash equivalents at beginning of period		142,245			119,168
Cash and cash equivalents at end of period	$	119,595		$	133,102
Supplemental disclosure of cash flow information:
Dividends paid with company stock	$	231		$	185
Cash paid for interest, net of amount capitalized of $201 and $556 for the periods ended September 2, 2017 and August 27, 2016, respectively	$	25,823		$	20,436
Cash paid for income taxes, net of refunds	$	22,044		$	33,428

7

H.B. FULLER COMPANY AND SUBSIDIARIES

Notes to Condensed Consolidated Financial Statements

(Amounts in thousands, except share and per share amounts)

(Unaudited)

Note 1: Basis of Presentation

The accompanying unaudited interim Condensed Consolidated Financial Statements of H.B. Fuller Company and Subsidiaries have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information necessary for a fair presentation of results of operations, comprehensive income, financial position, and cash flows in conformity with U.S. generally accepted accounting principles. In our opinion, the unaudited interim Condensed Consolidated Financial Statements reflect all adjustments of a normal recurring nature considered necessary for the fair presentation of the results for the periods presented. Operating results for interim periods are not necessarily indicative of results that may be expected for the fiscal year as a whole.

The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses and related disclosures at the date of the financial statements and during the reporting period. Actual results could differ from these estimates. These unaudited interim Condensed Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and Notes thereto included in our Annual Report on Form 10-K for the year ended December 3, 2016 as filed with the Securities and Exchange Commission.

On December 4, 2016, for our subsidiaries in Latin America, we changed the functional currency from the U.S. dollar to the entity’s local currency based on management’s analysis of the changes of the economic facts and circumstances in which these subsidiaries operate. The change in functional currency is accounted for prospectively from December 4, 2016 and financial statements prior to and including the nine months ended August 27, 2016 and the year ended December 3, 2016 have not been restated for the change in functional currency. Monetary assets and liabilities have been remeasured to the U.S. dollar at current exchange rates. Non-monetary assets (property, plant and equipment, net; goodwill; and intangible assets, net) have been remeasured to reflect the difference between the exchange rate when the asset arose and the exchange rate on the date of the change in functional currency. As a result of this change in functional currency, we recorded an $11,317 cumulative translation adjustment included in other comprehensive income for the nine months ended September 2, 2017.

New Accounting Pronouncements

In August 2017, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities. The ASU simplifies certain aspects of hedge accounting and improves disclosures of hedging arrangements through the elimination of the requirement to separately measure and report hedge ineffectiveness. The ASU generally requires the entire change in the fair value of a hedging instrument to be presented in the same income statement line as the hedged item in order to align financial reporting of hedge relationships with economic results. Entities must apply the amendments to cash flow and net investment hedge relationships that exist on the date of adoption using a modified retrospective approach. The presentation and disclosure requirements must be applied prospectively. Our effective date for adoption of this guidance is our fiscal year beginning December 1, 2019. We are currently evaluating the effect that this guidance will have on our Consolidated Financial Statements.

In May 2017, the FASB issued ASU No. 2017-09, Compensation—Stock Compensation (Topic 718): Scope of Modification Accounting. The ASU was issued to provide guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting. Our effective date for adoption of this guidance is our fiscal year beginning December 2, 2018 with early adoption permitted. We will apply this guidance to applicable transactions after the adoption date.

In March 2017, the FASB issued ASU No. 2017-07, Compensation—Retirement Benefits (Topic 715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost, which requires employers to include only the service cost component of net periodic pension cost and net periodic postretirement benefit cost in operating expenses. The other components of net benefit cost, including amortization of prior service cost/credit, and settlement and curtailment effects, are to be included in nonoperating expenses. The ASU also stipulates that only the service cost component of net benefit cost is eligible for capitalization. Our effective date for adoption of this guidance is our fiscal year beginning December 2, 2018 with early adoption permitted. We are currently evaluating the effect that this guidance will have on our Consolidated Financial Statements.

8

In February 2017, the FASB issued ASU No. 2017-05, Other Income—Gains and Losses from the Derecognition of Nonfinancial Assets (Subtopic 610-20): Clarifying the Scope of Asset Derecognition Guidance and Accounting for Partial Sales of Nonfinancial Assets. The ASU was issued to clarify the scope of the previous standard and to add guidance for partial sales of nonfinancial assets. Our effective date for adoption of this guidance is our fiscal year beginning December 2, 2018. We have evaluated the effect that this guidance will have on our Consolidated Financial Statements and related disclosures and determined it will not have a material impact.

In January 2017, the FASB issued ASU No. 2017-04, Intangibles—Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment, which removes Step 2 of the goodwill impairment test. A goodwill impairment will now be the amount by which a reporting unit’s carrying value exceeds its fair value, not to exceed the carrying amount of goodwill. Our effective date for prospective adoption of this guidance is our fiscal year beginning November 29, 2020 with early adoption permitted. We will apply this guidance to applicable impairment tests after the adoption date.

In January 2017, the FASB issued ASU No. 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a Business. This ASU clarifies the definition of a business when evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. We adopted ASU 2017-01 during the quarter ended September 2, 2017 on a prospective basis. There was no material impact of adopting this ASU.

In November 2016, the FASB issued ASU No. 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash (a consensus of the FASB Emerging Issues Task Force). This ASU requires that the reconciliation of the beginning-of-period and end-of-period amounts shown in the statement of cash flows include cash and restricted cash equivalents. Our effective date for adoption of this guidance is our fiscal year beginning December 2, 2018. We have evaluated the effect that this guidance will have on our Consolidated Financial Statements and related disclosures and determined it will not have a material impact.

In October 2016, the FASB issued ASU No. 2016-17, Consolidation (Topic 810): Interests Held through Related Parties That Are under Common Control. This ASU changes how a decision maker treats indirect interests in a managed variable interest entity held through an entity under common control in its primary beneficiary (consolidation) analysis. Our effective date for adoption of this guidance is our fiscal year beginning December 3, 2017. We have evaluated the effect that this guidance will have on our Consolidated Financial Statements and related disclosures and determined it will not have a material impact.

In October 2016, the FASB issued ASU No. 2016-16, Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory. This ASU changes the timing of income tax recognition for an intercompany sale of assets. The ASU requires the seller’s tax effects and the buyer’s deferred taxes to be recognized immediately upon the sale instead of deferring accounting for the income tax implications until the assets are sold to a third party or recovered through use. Our effective date for adoption of this guidance is our fiscal year beginning December 2, 2018. We are currently evaluating the effect that this guidance will have on our Consolidated Financial Statements.

In August 2016, the FASB issued ASU No. 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments (a consensus of the Emerging Issues Task Force). This ASU requires changes in the presentation of certain items including but not limited to debt prepayment or debt extinguishment costs; contingent consideration payments made after a business combination; proceeds from the settlement of insurance claims; proceeds from the settlement of corporate-owned life insurance policies and distributions received from equity method investees. Our effective date for adoption of this guidance is our fiscal year beginning December 2, 2018. We are currently evaluating the effect that this guidance will have on our Consolidated Financial Statements.

In June 2016, the FASB ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326), Measurement of Credit Losses on Financial Statements. This ASU requires a financial asset (or a group of financial assets) measured at amortized cost basis to be presented at the net amount expected to be collected. The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial asset(s) to present the net carrying value at the amount expected to be collected on the financial asset. Our effective date for adoption of this guidance is our fiscal year beginning November 29, 2020. We are currently evaluating the effect that this guidance will have on our Consolidated Financial Statements.

In March 2016, the FASB issued ASU No. 2016-09, Compensation - Stock Compensation (Topic 718), Improvements to Employee Share-Based Payment Accounting. This ASU provides simplification in the accounting for share-based payment transactions including the accounting for income taxes, forfeitures, statutory tax withholding requirements and classification in the statement of cash flows. Our effective date for adoption of this guidance is our fiscal year beginning December 3, 2017. We are currently evaluating the effect that this guidance will have on our Consolidated Financial Statements.

9

In March 2016, the FASB issued ASU No. 2016-08, Revenue from Contracts with Customers (Topic 606), Principal versus Agent Considerations (Reporting Revenue Gross versus Net). This ASU provides guidance on recording revenue on a gross basis versus a net basis based on the determination of whether an entity is a principal or an agent when another party is involved in providing goods or services to a customer. The amendments in this ASU affect the guidance in ASU No. 2014-09 and are effective in the same timeframe as ASU No. 2014-09 as discussed below.

In February 2016, the FASB issued ASU No. 2016-02, Leases (Subtopic 842). This guidance changes accounting for leases and requires lessees to recognize the assets and liabilities arising from all leases, including those classified as operating leases under previous accounting guidance, on the balance sheet and requires disclosure of key information about leasing arrangements to increase transparency and comparability among organizations. Our effective date for adoption of this guidance is our fiscal year beginning December 1, 2019 with early adoption permitted. The new guidance must be adopted using a modified retrospective transition approach, and provides for certain practical expedients. We are currently evaluating the impact that the new guidance will have on our Consolidated Financial Statements.

In January 2016, the FASB issued ASU No. 2016-01, Financial Instruments - Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities, which requires that equity investments (except those accounted for under the equity method of accounting or those that result in consolidation of the investee) are to be measured at fair value with changes in fair value recognized in net income. However, an entity may choose to measure equity investments that do not have readily determinable fair values at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. Furthermore, equity investments without readily determinable fair values are to be assessed for impairment using a quantitative approach. Our effective date for adoption of this guidance is our fiscal year beginning December 2, 2018. We have evaluated the effect that this guidance will have on our Consolidated Financial Statements and related disclosures and determined it will not have a material impact.

In July 2015, the FASB issued ASU No. 2015-11, Inventory (Topic 330): Simplifying the Measurement of Inventory, which requires a company to measure inventory within the scope of this guidance (inventory measured using first-in, first-out (FIFO) or average cost) at the lower of cost and net realizable value methods. Subsequent measurement is unchanged for inventory measured using the last-in, first-out (LIFO) or retail inventory method. Our effective date for adoption of this guidance is our fiscal year beginning December 3, 2017. We have evaluated the effect that this guidance will have on our Consolidated Financial Statements and related disclosures and determined it will not have a material impact.

In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606), which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. This guidance will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective. The new standard is effective for fiscal years and interim periods beginning after December 15, 2017 (as stated in ASU No. 2015-14 which defers the effective date and was issued in August 2015) and is now effective for our fiscal year beginning December 2, 2018. Early application as of the original effective date is permitted under ASU 2015-14. The standard permits the use of either the retrospective or cumulative effect transition method. We are continuing to evaluate the effect this guidance will have on our Consolidated Financial Statements, including potential impacts on the timing of revenue recognition and additional information that may be necessary for expanded disclosures regarding revenue. We have identified an implementation project team and related oversight processes and are continuing with the assessment phase of the project. We have not concluded as to whether the new guidance will be adopted on a full or modified retrospective basis, but will not apply the early adoption provisions of the new guidance.

10

Note 2: Acquisitions

Royal Adhesives

On September 2, 2017, we signed an agreement to purchase Royal Adhesives and Sealants (“Royal Adhesives”) for $1,575,000, subject to customary adjustments. The acquisition will be financed through new debt financing. Royal Adhesives, a manufacturer of high-value specialty adhesives and sealants, is a supplier of industrial adhesives in a diverse set of end markets, including aerospace, transportation, commercial roofing, insulating glass, solar, packaging and flooring applications and operates 19 manufacturing facilities in five countries. The acquisition is expected to expand our presence in North America, Europe and China and add new technology and packaging capabilities. The acquisition is expected to close during the fourth quarter of 2017.

The Stock Purchase Agreement contains certain limited termination rights for all parties, including, among others, the right to terminate if the transaction is not completed by March 2, 2018.  In certain specified circumstances, upon termination of the Stock Purchase Agreement by the seller, including a termination by the seller for our breach, we will be required to pay the seller a termination fee equal to $78,800. 

Adecol

On July 14, 2017, we entered into an agreement to purchase Adecol Ind. Quimica, Limitada (“Adecol”) for approximately 145,000 Brazilian real. Adecol is headquartered in Guarulhos, Brazil and works with customers to develop innovative, high-quality hot melt, reactive and polymer-based adhesive solutions in the packaging, converting and assembly markets. The acquisition is expected to enhance our business in Brazil by partnering with customers to produce new and better consumer and durable goods products in this region. The acquisition is expected to close during the fourth quarter of 2017.

Wisdom Adhesives 

On January 27, 2017, we acquired substantially all of the assets of H.E. Wisdom & Sons, Inc. and its affiliate Wisdom Adhesives Southeast, L.L.C., (“Wisdom Adhesives”) headquartered in Elgin, Illinois. Wisdom Adhesives is a provider of adhesives for the packaging, paper converting and assembly markets. The acquisition will strengthen our position in the North America adhesives market. The purchase price of $123,305 was financed through borrowings on our revolving credit facility and was recorded in our Americas Adhesives operating segment. We incurred acquisition related costs of approximately $555, which were recorded as SG&A expenses in the Condensed Consolidated Statement of Income for the nine months ended September 2, 2017. 

The acquisition fair value measurement was preliminary as of September 2, 2017, subject to the completion of the valuation of Wisdom Adhesives and payment of any excess working capital amounts to the seller. We expect the fair value measurement process to be completed when the final appraisals are available, but no later than twelve months from the acquisition date.

11

The following table summarizes the preliminary fair value measurement of the assets acquired and liabilities assumed as of the date of acquisition:

	Preliminary						Preliminary
	Valuation			Fair Value			Valuation
	March 4, 2017			Adjustments			September 2, 2017
Current assets	$	13,729		$	(31	)	$	13,698
Property, plant and equipment		10,516			(1,885	)		8,631
Goodwill		60,313			(792	)		59,521
Other intangibles
Customer relationships		33,300			12,000			45,300
Trademarks/trade names		13,600			(9,200	)		4,400
Current liabilities		(8,153	)		(92	)		(8,245	)
Total purchase price	$	123,305		$	-		$	123,305

The preliminary expected lives of the acquired intangible assets are 15 years for customer relationships and 10 years for trademarks/trade names.

Based on the preliminary fair value measurement of the assets acquired and liabilities assumed, we allocated $59,521 to goodwill for the expected synergies from combining Wisdom Adhesives with our existing business. Such goodwill is deductible for tax purposes. The goodwill was assigned to our Americas Adhesives operating segment. The Wisdom Adhesives acquisition does not represent a material business combination, and therefore pro forma financial information is not provided.

Cyberbond

On June 8, 2016, we acquired Cyberbond, L.L.C., (“Cyberbond”) headquartered in Batavia, Illinois with operations in the United States and Europe. Cyberbond is a provider of industrial adhesives for the electronics, medical, audio equipment, automotive and structural markets. The acquisition will help us to broaden our global position and accelerate our growth in the high margin, high growth Engineering Adhesives segment. The purchase price of $42,182, net of cash acquired of $332, was funded through existing cash and was recorded in our Engineering Adhesives operating segment. We incurred acquisition related costs of approximately $527, which were recorded as SG&A expenses in the Condensed Consolidated Statement of Income for the year ended December 3, 2016.

The following table summarizes the final fair value measurement of the assets acquired and liabilities assumed as of the date of acquisition:

	Amount
Current assets	$	4,425
Property, plant and equipment		2,038
Goodwill		23,654
Other intangibles
Developed technology		2,000
Customer relationships		14,400
Trademarks/trade names		700
Other assets		161
Current liabilities		(1,889	)
Long-term liabilities		(3,307	)
Total purchase price	$	42,182

The expected lives of the acquired intangible assets are seven years for developed technology, 15 years for customer relationships and 10 years for trademarks/trade names.

12

Based on the fair value measurement of the assets acquired and liabilities assumed, we allocated $23,654 to goodwill for the expected synergies from combining Cyberbond with our existing business. The amount of goodwill deductible for tax purposes is $10,658. The goodwill was assigned to our Engineering Adhesives operating segment. The Cyberbond acquisition does not represent a material business combination, and therefore pro forma financial information is not provided.

Advanced Adhesives

On April 29, 2016, we acquired Advanced Adhesives Pty Limited and the business assets of Advanced Adhesives (New Zealand) Limited (together referred to as “Advanced Adhesives”), providers of industrial adhesives in Australia and New Zealand. The acquisition will help us to strengthen our industrial adhesives market position and leverage a broader technology portfolio in both Australia and New Zealand. The combined purchase price of $10,365 was funded through existing cash and was recorded in our Asia Pacific operating segment. We incurred acquisition related costs of approximately $646, which were recorded as SG&A expenses in the Condensed Consolidated Statements of Income for the year ended December 3, 2016.

The following table summarizes the final fair value measurement of the assets acquired and liabilities assumed as of the date of acquisition:

	Amount
Current assets	$	5,704
Property, plant and equipment		594
Goodwill		102
Other intangibles
Customer relationships		7,575
Trademarks/trade names		146
Current liabilities		(2,671	)
Long-term liabilities		(1,085	)
Total purchase price	$	10,365

The expected lives of the acquired intangible assets are 15 years for customer relationships and one year for trademarks/trade names.

Based on the fair value measurement of the assets acquired and liabilities assumed, we allocated $102 to goodwill for the expected synergies from combining Advanced Adhesives with our existing business. Such goodwill is not deductible for tax purposes. The goodwill was assigned to our Asia Pacific operating segment. The Advanced Adhesives acquisition does not represent a material business combination, and therefore pro forma financial information is not provided.

Note 3: Restructuring Actions

Business Integration Project

The integration of the industrial adhesives business we acquired in March 2012 involved a significant amount of restructuring and capital investment to optimize the new combined entity. In addition, we took a series of actions in our existing EIMEA operating segment to improve the profitability and future growth prospects of this operating segment. We combined these two initiatives into a single project which we refer to as the “Business Integration Project.” During the third quarter and nine months ended August 27, 2016, we incurred costs of $2,807 and $2,024 related to transformation costs, workforce reduction costs, facility exit costs and other related costs for the Business Integration Project, which are included in special charges, net in the Condensed Consolidated Statements of Income. The Business Integration Project was substantially complete at the end of 2016.

2017 Restructuring Plan

During the first quarter of 2017, we approved a restructuring plan (the “2017 Restructuring Plan”) related to organizational changes and other actions to optimize operations. The 2017 Restructuring Plan was implemented in the first quarter of 2017 and is currently expected to be completed by mid-year of fiscal 2018. During the three and nine months ended September 2, 2017, we recorded a pre-tax charge of $1,270 and $17,072 respectively, related to the implementation of the 2017 Restructuring Plan.

13

The following table summarizes the pre-tax distribution of restructuring charges by income statement classification:

	Three Months Ended		Nine Months Ended
	September 2, 2017		September 2, 2017
Cost of sales	$	471	$	9,370
Selling, general and administrative		799		7,702
	$	1,270	$	17,072

The following table summarizes the pre-tax impact of restructuring charges by segment:

	Three Months Ended		Nine Months Ended
	September 2, 2017		September 2, 2017
Americas Adhesives	$	283	$	2,048
EIMEA		704		6,759
Asia Pacific		45		1,932
Construction Products		164		5,622
Engineering Adhesives		74		711
	$	1,270	$	17,072

A summary of the restructuring liability during the nine months ended September 2, 2017 is presented below:

	Employee- Related			Asset-Related			Other			Total
Balance at December 3, 2016	$	-		$	-		$	-		$	-
Expenses incurred		10,130			5,185			1,757			17,072
Non-cash charges		-			(4,291	)		-			(4,291	)
Cash payments		(7,158	)		(894	)		(1,746	)		(9,798	)
Foreign currency translation		448			-			-			448
Balance at September 2, 2017	$	3,420		$	-		$	11		$	3,431

Non-cash charges include accelerated depreciation resulting from the cessation of use of certain long-lived assets and the recording of a provision related to the discontinuance of certain retail and wholesale products. Restructuring liabilities have been classified as a component of other accrued expenses on the Condensed Consolidated Balance Sheets.

Note 4: Inventories

The composition of inventories is as follows:

	September 2,			December 3,
	2017			2016
Raw materials	$	149,332		$	116,200
Finished goods		180,682			142,397
LIFO reserve		(12,046	)		(11,198	)
Total inventories	$	317,968		$	247,399

14

Note 5: Goodwill and Other Intangible Assets

The goodwill activity for the nine months ended September 2, 2017 is presented below:

	Americas					Asia		Construction		Engineering
	Adhesives			EIMEA		Pacific		Products		Adhesives		Total
Balance at December 3, 2016	$	59,821		$	98,876	$	17,481	$	21,901	$	168,169	$	366,248
Acquisitions		59,521	1		-		-		-		-		59,521
Currency impact		654			8,930		314		22		8,953		18,873
Balance at September 2, 2017	$	119,996		$	107,806	$	17,795	$	21,923	$	177,122	$	444,642

¹ Preliminary goodwill balance as of September 2, 2017.

Balances of amortizable identifiable intangible assets, excluding goodwill and other non-amortizable intangible assets, are as follows:

	September 2, 2017
Amortizable Intangible Assets	Purchased Technology & Patents			Customer Relationships			All Other			Total
Original cost	$	72,563		$	305,863		$	56,467		$	434,893
Accumulated amortization		(31,751	)		(129,732	)		(35,482	)		(196,965	)
Net identifiable intangibles	$	40,812		$	176,131		$	20,985		$	237,928

	December 3, 2016
Amortizable Intangible Assets	Purchased Technology & Patents			Customer Relationships			All Other			Total
Original cost	$	70,504		$	251,329		$	51,116		$	372,949
Accumulated amortization		(21,448	)		(116,411	)		(30,198	)		(168,057	)
Net identifiable intangibles	$	49,056		$	134,918		$	20,918		$	204,892

Amortization expense with respect to amortizable intangible assets was $7,899 and $7,023 for the third quarter ended September 2, 2017 and August 27, 2016, respectively, and $23,128 and $20,509 for the nine months ended September 2, 2017 and August 27, 2016, respectively.

Estimated aggregate amortization expense based on the current carrying value of amortizable intangible assets for the next five fiscal years are as follows:

	Remainder of
Fiscal Year	2017		2018		2019		2020		2021		Thereafter
Amortization Expense	$	9,070	$	32,619	$	30,407	$	27,998	$	26,519	$	111,315

Non-amortizable intangible assets as of September 2, 2017 are $556 and are related to trademarks and trade names.

15

Note 6: Long-Term Debt

On February 14, 2017, we issued $300,000 aggregate principal of 10-year unsecured public notes (“4.000% Notes”) due February 15, 2027 with a fixed coupon of 4.00 percent.  Proceeds from this debt issuance were used to repay $138,000 outstanding under the revolving credit facility and prepay $158,750 of our term loan.  We entered into interest rate swap agreements to convert $150,000 of the $300,000 4.000% Notes to a variable interest rate of 1-month LIBOR (in advance) plus 1.86 percent.

On April 12, 2017, we entered into a credit agreement with a consortium of financial institutions under which we established a $400,000 multi-currency revolving credit facility and a $100,000 term loan that we can use to repay existing indebtedness, finance working capital needs, finance acquisitions and for general corporate purposes. Interest on the revolving credit facility is payable at LIBOR plus 1.10 percent. A facility fee of 0.15 percent is payable quarterly. The interest rate on the term loan is payable at LIBOR plus 1.25 percent. The interest rates and the facility fee are based on a ratings grid. The credit agreement replaced the previous credit agreement entered into on October 31, 2014. The April 12, 2017 credit agreement expires April 12, 2022.

During the second quarter ended June 3, 2017, we entered into an interest rate swap agreement to convert $125,000 of our Series E private placement to a variable interest rate of 1-month LIBOR (in arrears) plus 2.22 percent. See Note 13 for further discussion of the interest rate swaps.

We adopted ASU No. 2015-03, Interest-Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issue Costs, during the quarter ended March 4, 2017 on a retrospective basis. The impact of adopting ASU No. 2015-03 on our financial statements was the reclassification of deferred debt issuance costs related to our long-term debt, with the exception of our revolving credit line, from an asset to a direct deduction to the corresponding debt.  Reclassifications from an asset to a direct deduction to the corresponding debt of $2,386 was included in our Condensed Consolidated Balance Sheets as of December 3, 2016. 

Note 7: Redeemable Non-Controlling Interest

We account for the non-controlling interest in H.B. Fuller Kimya Sanayi Ticaret A.S. (“HBF Kimya”) as a redeemable non-controlling interest because both the non-controlling shareholder and H.B. Fuller had an option, exercisable beginning August 1, 2018, to require the redemption of the shares owned by the non-controlling shareholder at a price determined by a formula based on 24 months trailing EBITDA. Since the option made the redemption of the non-controlling ownership shares of HBF Kimya outside of our control, these shares are classified as a redeemable non-controlling interest in temporary equity in the Condensed Consolidated Balance Sheets. The non-controlling shareholder was entitled to increase his ownership by 1 percent per year for 5 years up to a maximum of 13 percent ownership based on the achievement of profitability targets in each year. The option was subject to a minimum price of €3,500.

The results of operations for the HBF Kimya non-controlling interest is consolidated in our financial statements. Both the non-controlling interest and the accretion adjustment to redemption value are included in net income attributable to non-controlling interests in the Condensed Consolidated Statements of Income and in the carrying value of the redeemable non-controlling interest on the Condensed Consolidated Balance Sheets. HBF Kimya’s functional currency is the Turkish lira and changes in exchange rates affect the reported amount of the redeemable non-controlling interest.

During the first quarter of 2017, we purchased the remaining shares from the non-controlling shareholder for €4,206. The difference between the non-controlling interest balance and the purchase price was recorded in additional paid-in capital in the first quarter of 2017.

16

	Redeemable
	Non-Controlling
	Interest
Balance at December 3, 2016	$	4,277
Net income attributed to redeemable non-controlling interest		39
Purchase of redeemable non-controlling interest		(4,468	)
Foreign currency translation adjustment		152
Balance at September 2, 2017	$	-

Note 8: Accounting for Share-Based Compensation

Overview

We have various share-based compensation programs, which provide for equity awards including non-qualified stock options, restricted stock shares, restricted stock units, performance awards and deferred compensation. These equity awards fall under several plans and are described in detail in our Annual Report on Form 10-K for the year ended December 3, 2016.

Grant-Date Fair Value

We use the Black-Scholes option pricing model to calculate the grant-date fair value of an award. The fair value of options granted during the quarter ended September 2, 2017 and August 27, 2016 was calculated using the following weighted average assumptions:

	Three Months Ended						Nine Months Ended
	September 2, 2017		August 27, 2016				September 2, 2017				August 27, 2016
Expected life (in years)		4.75			4.75				4.75				4.74
Weighted-average expected volatility		23.91%			26.77%				24.84%				28.96%
Expected volatility		23.91%		25.71%	-	27.10%		23.91%	-	24.88%		25.71%	-	29.23%
Risk-free interest rate		1.85%			0.98%				1.89%				1.43%
Expected dividend yield		1.15%			1.26%				1.12%				1.54%
Weighted-average fair value of grants		$10.58			$9.38				$10.81				$7.72

Expected life – We use historical employee exercise and option expiration data to estimate the expected life assumption for the Black-Scholes grant-date valuation. We believe that this historical data is currently the best estimate of the expected term of a new option. We use a weighted-average expected life for all awards.

Expected volatility – Volatility is calculated using our stock’s historical volatility for the same period of time as the expected life. We have no reason to believe that our future volatility will differ materially from historical volatility.

Risk-free interest rate – The rate is based on the U.S. Treasury yield curve in effect at the time of the grant for the same period of time as the expected life.

Expected dividend yield – The calculation is based on the total expected annual dividend payout divided by the average stock price.

Expense

We use the straight-line attribution method to recognize share-based compensation expense for option awards, restricted stock shares and restricted stock units with graded and cliff vesting. Incentive stock options and performance awards are based on certain performance-based metrics and the expense is adjusted quarterly, based on our projections of the achievement of those metrics. The amount of share-based compensation expense recognized during a period is based on the value of the portion of the awards that are ultimately expected to vest. The expense is recognized over the requisite service period, which for us is the period between the grant-date and the earlier of the award’s stated vesting term or the date the employee is eligible for early vesting based on the terms of the plans.

17

Total share-based compensation expense of $3,191 and $2,501 was included in our Condensed Consolidated Statements of Income for the third quarter ended September 2, 2017 and August 27, 2016, respectively. Total share-based compensation expense of $12,034 and $9,469 was included in our Condensed Consolidated Statements of Income for the nine months ended September 2, 2017 and August 27, 2016, respectively. All share-based compensation expense was recorded as SG&A expense. For the third quarter ended September 2, 2017 and August 27, 2016, there was $151 and $870 of excess tax benefit recognized. For the nine months ended September 2, 2017 and August 27, 2016, there was $1,504 and $1,462 of excess tax benefit recognized.

As of September 2, 2017, there was $8,818 of unrecognized compensation costs related to unvested stock option awards, which is expected to be recognized over a weighted-average period of 1.1 years. Unrecognized compensation costs related to unvested restricted stock units was $14,376, which is expected to be recognized over a weighted-average period of 1.2 years.

Stock Option Activity

The stock option activity for the nine months ended September 2, 2017 is presented below:

				Average
	Options			Exercise Price
Outstanding at December 3, 2016		2,986,481		$	34.92
Granted		721,904			50.04
Exercised		(437,694	)		37.39
Forfeited or cancelled		(89,589	)		36.69
Outstanding at September 2, 2017		3,181,102		$	38.39

The total fair value of options granted during the quarter ended September 2, 2017 and August 27, 2016 was $46 and $47, respectively. Total intrinsic value of options exercised during the third quarter ended September 2, 2017 and August 27, 2016 was $474 and $3,365, respectively. Intrinsic value is the difference between our closing stock price on the respective trading day and the exercise price, multiplied by the number of options exercised. The total fair value of options granted during the nine months ended September 2, 2017 and August 27, 2016 were $7,803 and $6,509, respectively. Total intrinsic value of options exercised during the nine months ended September 2, 2017 and August 27, 2016 were $7,099 and $5,114, respectively.

Proceeds received from option exercises during the third quarter ended September 2, 2017 and August 27, 2016 was $1,107 and $2,677, respectively, and $15,033 and $9,760 during the nine months ended September 2, 2017 and August 27, 2016.

Restricted Stock Activity

The nonvested restricted stock activity for the nine months ended September 2, 2017 is presented below:

												Weighted-
										Weighted-		Average
										Average		Remaining
										Grant		Contractual
										Date Fair		Life
	Units			Shares			Total			Value		(in Years)
Nonvested at December 3, 2016		352,744			36,953			389,697		$	38.36		1.0
Granted		284,598			-			284,598			50.71		1.4
Vested		(154,516	)		(36,953	)		(191,469	)		39.92		-
Forfeited		(20,597	)		-			(20,597	)		39.06		1.3
Nonvested at September 2, 2017		462,229			-			462,229		$	44.72		1.2

Total fair value of restricted stock vested during the third quarter ended September 2, 2017 and August 27, 2016 was $250 and $25, respectively. Total fair value of restricted stock vested during the nine months ended September 2, 2017 and August 27, 2016 was $7,643 and $6,101, respectively. The total fair value of nonvested restricted stock at September 2, 2017 was $21,240.

18

We repurchased 1,837 and 189 restricted stock shares during the third quarter ended September 2, 2017 and August 27, 2016, respectively. We repurchased 55,646 and 67,742 restricted stock shares during the nine months ended September 2, 2017 and August 27, 2016, respectively. The repurchases relate to statutory minimum tax withholding.

Deferred Compensation Activity

We have a Directors’ Deferred Compensation plan that allows non-employee directors to defer all or a portion of their directors’ compensation in a number of investment choices, including units representing shares of our common stock. We also have a Key Employee Deferred Compensation Plan that allows key employees to defer a portion of their eligible compensation in a number of investment choices, including units, representing shares of our common stock. We provide a 10 percent match on deferred compensation invested into units, representing shares of our common stock. The deferred compensation unit activity for the nine months ended September 2, 2017 is presented below:

	Non-employee
	Directors			Employees			Total
Units outstanding December 3, 2016		424,319			41,116			465,435
Participant contributions		23,864			5,053			28,917
Company match contributions		2,386			505			2,891
Payouts		(14,143	)		(12,552	)		(26,695	)
Units outstanding September 2, 2017		436,426			34,122			470,548

Deferred compensation units are fully vested at the date of contribution.

Note 9: Components of Net Periodic Cost (Benefit) related to Pension and Other Postretirement Benefit Plans

	Three Months Ended September 2, 2017 and August 27, 2016
													Other
	Pension Benefits												Postretirement
	U.S. Plans						Non-U.S. Plans						Benefits
Net periodic cost (benefit):	2017			2016			2017			2016			2017			2016
Service cost	$	27		$	27		$	546		$	519		$	52		$	84
Interest cost		3,603			3,768			1,199			1,343			399			479
Expected return on assets		(6,365	)		(6,078	)		(2,510	)		(2,435	)		(1,447	)		(1,341	)
Amortization:
Prior service cost		8			7			(1	)		(1	)		-			(10	)
Actuarial loss		1,308			1,292			893			788			251			532
Net periodic (benefit) cost	$	(1,419	)	$	(984	)	$	127		$	214		$	(745	)	$	(256	)

	Nine Months Ended September 2, 2017 and August 27, 2016
													Other
	Pension Benefits												Postretirement
	U.S. Plans						Non-U.S. Plans						Benefits
Net periodic cost (benefit):	2017			2016			2017			2016			2017			2016
Service cost	$	83		$	81		$	1,566		$	1,480		$	156		$	252
Interest cost		10,809			11,303			3,490			4,076			1,195			1,439
Expected return on assets		(19,093	)		(18,232	)		(7,301	)		(7,400	)		(4,341	)		(4,025	)
Amortization:
Prior service cost		22			21			(3	)		(3	)		-			(30	)
Actuarial loss		3,922			3,878			2,581			2,293			757			1,596
Net periodic (benefit) cost	$	(4,257	)	$	(2,949	)	$	333		$	446		$	(2,233	)	$	(768	)

19

Note 10: Accumulated Other Comprehensive Income (Loss)

The following table provides details of total comprehensive income (loss):

	Three Months Ended September 2, 2017												Three Months Ended August 27, 2016
	H.B. Fuller Stockholders									Non- controlling Interests			H.B. Fuller Stockholders							Non- controlling Interests
	Pre-tax			Tax			Net			Net			Pre-tax		Tax			Net		Net
Net income including non-controlling interests		-			-		$	25,138		$	1			-		-		$	32,745	$	53
Foreign currency translation adjustment¹	$	29,102			-			29,102			(12	)	$	3,368		-			3,368		-
Reclassification to earnings:
Defined benefit pension plans adjustment²		2,459		$	(832	)		1,627			-			2,585	$	(908	)		1,677		-
Interest rate swap³		16			(6	)		10			-			16		(6	)		10		-
Cash-flow hedges³		(160	)		61			(99	)		-			56		(21	)		35		-
Other comprehensive income (loss)	$	31,417		$	(777	)		30,640			(12	)	$	6,025	$	(935	)		5,090		-
Comprehensive income (loss)							$	55,778		$	(11	)						$	37,835	$	53

	Nine Months Ended September 2, 2017										Nine Months Ended August 27, 2016
	H.B. Fuller Stockholders							Non- controlling Interests			H.B. Fuller Stockholders									Non- controlling Interests
	Pretax		Tax			Net		Net			Pretax			Tax			Net			Net
Net income including non-controlling interests		-		-		$	65,800	$	34			-			-		$	84,994		$	161
Foreign currency translation adjustment¹	$	37,095		-			37,095		(11	)	$	3,860			-			3,860			-
Reclassification to earnings:
Defined benefit pension plans adjustment²		7,279	$	(2,469	)		4,810		-			7,755		$	(2,723	)		5,032			-
Interest rate swap³		48		(18	)		30		-			45			(15	)		30			-
Cash-flow hedges³		11		(4	)		7		-			(252	)		96			(156	)		-
Other comprehensive income (loss)	$	44,433	$	(2,491	)		41,942		(11	)	$	11,408		$	(2,642	)		8,766			-
Comprehensive income (loss)						$	107,742	$	23								$	93,760		$	161

¹ Income taxes are not provided for foreign currency translation relating to permanent investments in international subsidiaries. As discussed in Note 1, the foreign currency translation adjustment for the quarter and nine months ended September 2, 2017 includes the impact of the change in functional currency for our subsidiaries in Latin America.

² Loss reclassified from accumulated other comprehensive income ("AOCI") into earnings as part of net periodic cost related to pension and other postretirement benefit plans is reported in cost of sales, SG&A expense and special charges, net.

³ Loss reclassified from AOCI into earnings is reported in other income (expense), net.

20

The components of accumulated other comprehensive loss is as follows:

	September 2, 2017
	Total			H.B. Fuller Stockholders			Non-controlling Interests
Foreign currency translation adjustment	$	(48,363	)	$	(48,286	)	$	(77	)
Defined benefit pension plans adjustment, net of taxes of $88,265		(171,291	)		(171,291	)		-
Interest rate swap, net of taxes of ($36)		58			58			-
Cash-flow hedges, net of taxes of $780		(1,268	)		(1,268	)		-
Accumulated other comprehensive loss	$	(220,864	)	$	(220,787	)	$	(77	)

	December 3, 2016
	Total			H.B. Fuller Stockholders			Non-controlling Interests
Foreign currency translation adjustment	$	(85,447	)	$	(85,381	)	$	(66	)
Defined benefit pension plans adjustment, net of taxes of $90,734		(176,101	)		(176,101	)		-
Interest rate swap, net of taxes of ($17)		28			28			-
Cash-flow hedges, net of taxes of $785		(1,275	)		(1,275	)		-
Accumulated other comprehensive loss	$	(262,795	)	$	(262,729	)	$	(66	)

Note 11: Income Taxes

As of September 2, 2017, we had a liability of $4,997 recorded under FASB ASC 740, Income Taxes, for gross unrecognized tax benefits (excluding interest), compared to $4,165 as of December 3, 2016. As of September 2, 2017, we had accrued $838 of gross interest relating to unrecognized tax benefits. For the quarter ended September 2, 2017, our recorded liability for gross unrecognized tax benefits increased by $489.

Note 12: Earnings Per Share

A reconciliation of the common share components for the basic and diluted earnings per share calculations is as follows:

	Three Months Ended				Nine Months Ended
	September 2,		August 27,		September 2,		August 27,
(Shares in thousands)	2017		2016		2017		2016
Weighted-average common shares - basic		50,384		50,261		50,374		50,122
Equivalent shares from share-based compensations plans		1,221		1,192		1,210		1,112
Weighted-average common and common equivalent shares - diluted		51,605		51,453		51,584		51,234

Basic earnings per share is calculated by dividing net income attributable to H.B. Fuller by the weighted-average number of common shares outstanding during the applicable period. Diluted earnings per share is based upon the weighted-average number of common and common equivalent shares outstanding during the applicable period. The difference between basic and diluted earnings per share is attributable to share-based compensation awards. We use the treasury stock method to calculate the effect of outstanding shares, which computes total employee proceeds as the sum of (a) the amount the employee must pay upon exercise of the award, (b) the amount of unearned share-based compensation costs attributed to future services and (c) the amount of tax benefits, if any, that would be credited to additional paid-in capital assuming exercise of the award. Share-based compensation awards for which total employee proceeds exceed the average market price over the applicable period have an antidilutive effect on earnings per share, and accordingly, are excluded from the calculation of diluted earnings per share.

21

Options to purchase 27,942 and 386,496 shares of common stock at a weighted-average exercise price of $52.32 and $48.57 for the quarters ended September 2, 2017 and August 27, 2016, respectively, were excluded from the diluted earnings per share calculations because they were antidilutive. Options to purchase 97,687 and 762,509 shares of common stock at a weighted-average exercise price of $50.37 and $44.86 for the nine months ended September 2, 2017 and August 27, 2016, respectively, were excluded from the diluted earnings per share calculations because they were antidilutive.

Note 13: Financial Instruments

Overview

As a result of being a global enterprise, our earnings, cash flows and financial position are exposed to foreign currency risk from foreign currency denominated receivables and payables.

We use foreign currency forward contracts, cross-currency swaps, and interest rate swaps to manage risks associated with foreign currency exchange rates and interest rates. We do not hold derivative financial instruments of a speculative nature or for trading purposes. We record derivatives as assets and liabilities on the balance sheet at fair value. Changes in fair value are recognized immediately in earnings unless the derivative qualifies and is designated as a hedge. Cash flows from derivatives are classified in the statement of cash flows in the same category as the cash flows from the items subject to the designated hedge or undesignated (economic) hedge relationship. We evaluate hedge effectiveness at inception and on an ongoing basis. If a derivative is no longer expected to be effective, hedge accounting is discontinued. Hedge ineffectiveness, if any, is recorded in earnings.

We are exposed to credit risk in the event of nonperformance of counterparties for foreign currency forward exchange contracts and interest rate swap agreements. We select investment-grade multinational banks and financial institutions as counterparties for derivative transactions and monitor the credit quality of each of these banks on periodic basis as warranted. We do not anticipate nonperformance by any of these counterparties, and valuation allowances, if any, are de minimis.

Cash Flow Hedges

Effective February 24, 2017, we entered into a cross-currency swap agreement to convert a notional amount of $42,600 of foreign currency denominated intercompany loans into U.S. dollars. The swap matures in 2020.

Effective October 7, 2015, we entered into three cross-currency swap agreements to convert a notional amount of $134,736 of foreign currency denominated intercompany loans into U.S. dollars. The first swap matures in 2017, the second swap matures in 2018 and the third swap matures in 2019.

As of September 2, 2017, the combined fair value of the swaps was a liability of $14,493 and was included in other liabilities in the Condensed Consolidated Balance Sheets. The swaps were designated as cash-flow hedges for accounting treatment. The lesser amount between the cumulative change in the fair value of the actual swaps and the cumulative change in the fair value of hypothetical swaps is recorded in accumulated other comprehensive income (loss) in the Condensed Consolidated Balance Sheets. The difference between the cumulative change in the fair value of the actual swaps and the cumulative change in the fair value of hypothetical swaps are recorded as other income (expense), net in the Condensed Consolidated Statements of Income. In a perfectly effective hedge relationship, the two fair value calculations would exactly offset each other. Any difference in the calculation represents hedge ineffectiveness. The ineffectiveness calculations as of September 2, 2017 resulted in additional pre-tax gain of $12 for the nine months ended September 2, 2017 as the change in fair value of the cross-currency swaps was more than the change in the fair value of the hypothetical swaps. The amount in accumulated other comprehensive income (loss) related to cross-currency swaps was a loss of $1,268 as of September 2, 2017. The estimated net amount of the existing loss that is reported in accumulated other comprehensive income (loss) as of September 2, 2017 that is expected to be reclassified into earnings within the next twelve months is $839. As of September 2, 2017, we do not believe any gains or losses will be reclassified into earnings as a result of the discontinuance of these cash flow hedges because the original forecasted transaction will not occur.

22

The following table summarizes the cross-currency swaps outstanding as of September 2, 2017:

	Fiscal Year of Expiration	Interest Rate		Notional Value		Fair Value
Pay EUR	2017		3.05%	$	44,912	$	(2,568	)
Receive USD			3.9145%
Pay EUR	2018		3.45%	$	44,912	$	(3,155	)
Receive USD			4.5374%
Pay EUR	2019		3.80%	$	44,912	$	(3,688	)
Receive USD			5.0530%
Pay EUR	2020		1.95%	$	42,600	$	(5,082	)
Receive USD			4.30375%
Total				$	177,336	$	(14,493	)

Except for the cross-currency swap agreements listed above, foreign currency derivative instruments outstanding are not designated as hedges for accounting purposes. The gains and losses related to mark-to-market adjustments are recognized as other income or expense in the Condensed Consolidated Statements of Income during the periods in which the derivative instruments are outstanding. See Note 14 for the fair value amounts of these derivative instruments.

As of September 2, 2017, we had forward foreign currency contracts maturing between September 11, 2017 and April 13, 2018. The mark-to-market effect associated with these contracts, on a net basis, was a loss of $1,606 as of September 2, 2017. These losses were largely offset by the underlying transaction gains and losses resulting from the foreign currency exposures for which these contracts relate.

Fair Value Hedges

During the second quarter ended June 3, 2017, we entered into interest rate swap agreements to convert $125,000 of our Series E private placement to variable interest rates of 1-month LIBOR (in arrears) plus 2.22 percent. The combined fair value of the interest rate swaps in total was an asset of $1,103 at September 2, 2017 and was included in other assets in the Condensed Consolidated Balance Sheets. The swaps were designated for hedge accounting treatment as fair value hedges. We are applying the shortcut method in accounting for these interest rate swaps as we expect that the changes in the fair value of the swap will offset the changes in the fair value of the 5.61% Notes resulting in no ineffectiveness. As a result of applying the shortcut method, the change in the fair value of the interest rate swap and an equivalent amount for the change in the fair value of the debt will be reflected in other income (expense), net and no ineffectiveness will be recognized in our Condensed Consolidated Statements of Income.

23

We entered into interest rate swap agreements to convert $150,000 of our $300,000 4.000% Notes that were issued on February 14, 2017 to a variable interest rate of 1-month LIBOR (in advance) plus 1.86 percent. See Note 6 for further discussion on the issuance of our 4.000% Notes. The combined fair value of the interest rate swaps in total was an asset of $1,148 at September 2, 2017 and was included in other assets in the Condensed Consolidated Balance Sheets. The swaps were designated for hedge accounting treatment as fair value hedges. We are applying the shortcut method in accounting for these interest rate swaps as we expect that the changes in the fair value of the swap will offset the changes in the fair value of the 4.000% Notes resulting in no ineffectiveness. As a result of applying the shortcut method, the change in the fair value of the interest rate swap and an equivalent amount for the change in the fair value of the debt will be reflected in other income (expense), net and no ineffectiveness will be recognized in our Condensed Consolidated Statements of Income.

We entered into interest rate swap agreements to convert $75,000 of our senior notes that were issued in November 2009 to variable interest rates. At September 2, 2017, one swap remains in place to convert $25,000 of our 5.61% senior notes issued on December 16, 2009 to a variable interest rate of 6-month LIBOR (in arrears) plus 1.78 percent. The change in fair value of the senior notes, attributable to the change in the risk being hedged, was a liability of $1,049 at September 2, 2017 and was included in long-term debt and current maturities of long-term debt in the Condensed Consolidated Balance Sheets. The combined fair value of the swaps in total was an asset of $1,122 at September 2, 2017 and $1,579 at December 3, 2016 and were included in other assets in the Condensed Consolidated Balance Sheets. The swaps were designated for hedge accounting treatment as fair value hedges. The changes in the fair value of the swap and the fair value of the senior notes attributable to the change in the risk being hedged are recorded as other income (expense), net in the Condensed Consolidated Statements of Income. In a perfectly effective hedge relationship, the two fair value calculations would exactly offset each other. Any difference in the calculation represents hedge ineffectiveness. For the nine months ended September 2, 2017 and August 27, 2016, a pre-tax gain of $100 and $14, respectively, was recorded as the fair value of the senior notes decreased by more than the fair value of the interest rate swap attributable to the change in the risk being hedged.

Concentrations of credit risk with respect to trade accounts receivable are limited due to the large number of entities in the customer base and their dispersion across many different industries and countries. As of September 2, 2017, there were no significant concentrations of credit risk.

Note 14: Fair Value Measurements

Overview

Estimates of fair value for financial assets and liabilities are based on the framework established in the accounting guidance for fair value measurements. The framework defines fair value, provides guidance for measuring fair value and requires certain disclosures. The framework discusses valuation techniques, such as the market approach (comparable market prices), the income approach (present value of future income or cash flow) and the cost approach (cost to replace the service capacity of an asset or replacement cost). The framework utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels:

● Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities.

● Level 2: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly.  These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.

● Level 3: Unobservable inputs that reflect management’s assumptions, and include situations where there is little, if any, market activity for the asset or liability.

Balances Measured at Fair Value on a Recurring Basis

The following table presents information about our financial assets and liabilities that are measured at fair value on a recurring basis as of September 2, 2017 and December 3, 2016, and indicates the fair value hierarchy of the valuation techniques utilized to determine such fair value.

	September 2,		Fair Value Measurements Using:
Description	2017		Level 1		Level 2		Level 3
Assets:
Marketable securities	$	5,106	$	5,106	$	-	$	-
Foreign exchange contract assets		890		-		890		-
Interest rate swaps		3,373		-		3,373		-
Liabilities:
Foreign exchange contract liabilities	$	2,497	$	-	$	2,497	$	-
Contingent consideration liability		2,292		-		-		2,292
Cash-flow hedges		14,493		-		14,493		-

24

	December 3,		Fair Value Measurements Using:
Description	2016		Level 1		Level 2		Level 3
Assets:
Marketable securities	$	1,020	$	1,020	$	-	$	-
Foreign exchange contract assets		11,697		-		11,697		-
Interest rate swaps		1,579		-		1,579		-
Cash-flow hedges		4,654		-		4,654		-
Liabilities:
Foreign exchange contract liabilities	$	6,925	$	-	$	6,925	$	-
Contingent consideration liability		4,720		-		-		4,720

Long-term debt had an estimated fair value of $834,091 and $693,283 as of September 2, 2017 and December 3, 2016, respectively. The fair value of long-term debt is based on quoted market prices for the same or similar issues or on the current rates offered for debt of similar maturities. The estimated fair value of these long-term obligations is not necessarily indicative of the amount that would be realized in a current market exchange.

We use the income approach in calculating the fair value of our contingent consideration liability using a real option model with Level 3 inputs. The expected cash flows are affected by various significant judgments and assumptions, including revenue growth rates, profit margin percentages, volatility and discount rate, which are sensitive to change. Estimates of fair value are inherently uncertain and represent only management’s reasonable expectation regarding future developments. These estimates and the judgments and assumptions upon which the estimates are based will, in all likelihood, differ in some respects from actual future results. During the third quarter of 2017, we entered into an agreement to modify the terms of the earnout calculation associated with the contingent consideration liability. This modification results in an increase to the contingent consideration of liability by approximately $1,100.

The contingent consideration liability activity for the nine months ended September 2, 2017 is presented below:

	Amount
Balance at December 3, 2016	$	4,720
Mark to market adjustment		(3,573	)
Adjustment for amendment to agreement		1,120
Foreign currency translation adjustment		25
Balance at September 2, 2017	$	2,292

Note 15: Share Repurchase Program

On April 6, 2017 the Board of Directors authorized a share repurchase program of up to $200,000 of our outstanding common shares for a period up to five years. Under the program, we are authorized to repurchase shares for cash on the open market, from time to time, in privately negotiated transactions or block transactions, or through an accelerated repurchase agreement. The timing of such repurchases is dependent on price, market conditions and applicable regulatory requirements. Upon repurchase of the shares, we reduce our common stock for the par value of the shares with the excess being applied against additional paid-in capital. This authorization replaces the September 30, 2010 authorization to repurchase shares.

During the nine months ended September 2, 2017, we repurchased shares under the September 30, 2010 program with an aggregate value of $6,284. Of this amount, $125 reduced common stock and $6,159 reduced additional paid-in capital. During the nine months ended August 27, 2016, we repurchased shares with an aggregate value of $9,536. Of this amount, $250 reduced common stock and $9,286 reduced additional paid-in capital.

During the nine months ended September 2, 2017, we repurchased shares under the April 6, 2017 program with an aggregate value of $12,830. Of this amount, $250 reduced common stock and $12,580 reduced additional paid-in capital.

25

Note 16: Commitments and Contingencies

Environmental Matters

From time to time, we become aware of compliance matters relating to, or receive notices from, federal, state or local entities regarding possible or alleged violations of environmental, health or safety laws and regulations. We review the circumstances of each individual site, considering the number of parties involved, the level of potential liability or our contribution relative to the other parties, the nature and magnitude of the hazardous substances involved, the method and extent of remediation, the estimated legal and consulting expense with respect to each site and the time period over which any costs would likely be incurred. Also, from time to time, we are identified as a potentially responsible party (“PRP”) under the Comprehensive Environmental Response, Compensation and Liability Act and/or similar state laws that impose liability for costs relating to the clean up of contamination resulting from past spills, disposal or other release of hazardous substances. We are also subject to similar laws in some of the countries where current and former facilities are located. Our environmental, health and safety department monitors compliance with applicable laws on a global basis. To the extent we can reasonably estimate the amount of our probable liabilities for environmental matters, we establish a financial provision.

Currently we are involved in various environmental investigations, clean up activities and administrative proceedings and lawsuits. In particular, we are currently deemed a PRP in conjunction with numerous other parties, in a number of government enforcement actions associated with landfills and/or hazardous waste sites. As a PRP, we may be required to pay a share of the costs of investigation and clean up of these sites. In addition, we are engaged in environmental remediation and monitoring efforts at a number of current and former operating facilities. While uncertainties exist with respect to the amounts and timing of the ultimate environmental liabilities, based on currently available information, we have concluded that these matters, individually or in the aggregate, will not have a material adverse effect on our results of operations, financial condition or cash flow.

Other Legal Proceedings

From time to time and in the ordinary course of business, we are a party to, or a target of, lawsuits, claims, investigations and proceedings, including product liability, personal injury, contract, patent and intellectual property, environmental, health and safety, tax and employment matters. While we are unable to predict the outcome of these matters, we have concluded, based upon currently available information, that the ultimate resolution of any pending matter, individually or in the aggregate, including the asbestos litigation described in the following paragraphs, will not have a material adverse effect on our results of operations, financial condition or cash flow.

We have been named as a defendant in lawsuits in which plaintiffs have alleged injury due to products containing asbestos manufactured more than 30 years ago. The plaintiffs generally bring these lawsuits against multiple defendants and seek damages (both actual and punitive) in very large amounts. In many cases, plaintiffs are unable to demonstrate that they have suffered any compensable injuries or that the injuries suffered were the result of exposure to products manufactured by us. We are typically dismissed as a defendant in such cases without payment. If the plaintiff presents evidence indicating that compensable injury occurred as a result of exposure to our products, the case is generally settled for an amount that reflects the seriousness of the injury, the length, intensity and character of exposure to products containing asbestos, the number and solvency of other defendants in the case, and the jurisdiction in which the case has been brought.

A significant portion of the defense costs and settlements in asbestos-related litigation is paid by third parties, including indemnification pursuant to the provisions of a 1976 agreement under which we acquired a business from a third party. Currently, this third party is defending and paying settlement amounts, under a reservation of rights, in most of the asbestos cases tendered to the third party.

In addition to the indemnification arrangements with third parties, we have insurance policies that generally provide coverage for asbestos liabilities, including defense costs. Historically, insurers have paid a significant portion of our defense costs and settlements in asbestos-related litigation. However, certain of our insurers are insolvent. We have entered into cost-sharing agreements with our insurers that provide for the allocation of defense costs and settlements and judgments in asbestos-related lawsuits. These agreements require, among other things, that we fund a share of settlements and judgments allocable to years in which the responsible insurer is insolvent

26

A summary of the number of and settlement amounts for asbestos-related lawsuits and claims is as follows:

	Nine Months Ended				3 Years Ended
	September 2, 2017		August 27, 2016		December 3, 2016
Lawsuits and claims settled		7		9		33
Settlement amounts	$	1,605	$	978	$	3,061
Insurance payments received or expected to be received	$	1,312	$	645	$	2,253

We do not believe that it would be meaningful to disclose the aggregate number of asbestos-related lawsuits filed against us because relatively few of these lawsuits are known to involve exposure to asbestos-containing products that we manufactured. Rather, we believe it is more meaningful to disclose the number of lawsuits that are settled and result in a payment to the plaintiff. To the extent we can reasonably estimate the amount of our probable liabilities for pending asbestos-related claims, we establish a financial provision and a corresponding receivable for insurance recoveries. 

Based on currently available information, we have concluded that the resolution of any pending matter, including asbestos-related litigation, individually or in the aggregate, will not have a material adverse effect on our results of operations, financial condition or cash flow.

Note 17: Operating Segments

We are required to report segment information in the same way that we internally organize our business for assessing performance and making decisions regarding allocation of resources.  For segment evaluation by the chief operating decision maker, segment operating income is identified as gross profit less SG&A expenses.  Segment operating income excludes special charges, net.  Corporate expenses are fully allocated to each operating segment, except that, in the third quarter of 2017, $4,751 of charges related to transaction costs for the Royal Adhesives acquisition were not allocated to the operating segments.  Corporate assets are not allocated to the operating segments.  Inter-segment revenues are recorded at cost plus a markup for administrative costs.  Operating results of each segment are regularly reviewed by our chief operating decision maker to make decisions about resources to be allocated to the segments and assess their performance.

The table below provides certain information regarding net revenue and segment operating income for each of our operating segments:

	Three Months Ended
	September 2, 2017							August 27, 2016
			Inter-		Segment					Inter-		Segment
	Trade		Segment		Operating			Trade		Segment		Operating
	Revenue		Revenue		Income (Loss)			Revenue		Revenue		Income
Americas Adhesives	$	230,881	$	3,998	$	26,664		$	198,957	$	4,096	$	31,900
EIMEA		137,408		5,347		9,900			130,619		4,056		8,430
Asia Pacific		62,972		1,882		2,822			57,488		1,540		2,510
Construction Products		59,080		-		955			64,402		185		2,093
Engineering Adhesives		72,528		-		4,591			61,392		-		3,496
Corporate		-		-		(4,751	)		-				-
Total	$	562,869			$	40,181		$	512,858			$	48,429

	Nine Months Ended
	September 2, 2017							August 27, 2016
			Inter-		Segment					Inter-		Segment
	Trade		Segment		Operating			Trade		Segment		Operating
	Revenue		Revenue		Income (Loss)			Revenue		Revenue		Income
Americas Adhesives	$	653,665	$	11,855	$	74,152		$	588,422	$	11,821	$	94,043
EIMEA		396,674		13,246		19,779			394,807		13,821		25,620
Asia Pacific		190,083		4,385		9,452			171,467		3,801		9,299
Construction Products		179,880		-		(1,581	)		192,111		340		5,412
Engineering Adhesives		207,541		-		12,479			172,891		-		6,465
Corporate		-		-		(4,751	)		-				-
Total	$	1,627,843			$	109,530		$	1,519,698			$	140,839

27

The table below provides a reconciliation of segment operating income to income before income taxes and income from equity method investments:

	Three Months Ended						Nine Months Ended
	September 2,			August 27,			September 2,			August 27,
	2017			2016			2017			2016
Segment operating income	$	40,181		$	48,429		$	109,530		$	140,839
Special charges, net		-			2,807			-			2,024
Other income (expense), net		150			(956	)		661			(7,603	)
Interest expense		(8,100	)		(6,809	)		(24,628	)		(19,714	)
Income before income taxes and income from equity method investments	$	32,231		$	43,471		$	85,563		$	115,546

28

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

Overview

The Management’s Discussion and Analysis of Financial Condition and Results of Operations (MD&A) should be read in conjunction with the MD&A included in our Annual Report on Form 10-K for the year ended December 3, 2016 for important background information related to our business.

Net revenue in the third quarter of 2017 increased 9.8 percent from the third quarter of 2016. Revenue increased 9.9 percent due to sales volume, including 4.2 percent from acquisitions, and a 1.6 percent increase due to favorable product pricing, but was partially offset by a 0.2 percent decrease due to unfavorable sales mix compared to the third quarter of 2016. A weaker Egyptian pound, Turkish lira, Chinese renminbi, and Argentinian peso offset by a stronger Euro compared to the U.S. dollar for the third quarter of 2017 compared to the third quarter of 2016 were the main drivers of a negative 1.5 percent currency effect. Gross profit margin decreased 180 basis points primarily due to higher raw material costs and the implementation of the 2017 Restructuring Plan.

Net revenue in the first nine months of 2017 increased 7.1 percent from the first nine months of 2016. Revenue increased 10.3 percent due to sales volume, including 4.3 percent from acquisitions and 0.4 percent increase due to product pricing, but was partially offset by a 0.6 percent decrease due to unfavorable sales mix compared to the first nine months of 2016. A weaker Egyptian pound, Turkish lira, Chinese renminbi, Euro and Mexican peso compared to the U.S. dollar for the first nine months of 2017 compared to the first nine months of 2016 were the main drivers of a negative 3.0 percent currency effect. Gross profit margin decreased 240 basis points primarily due to higher raw material costs and the implementation of the 2017 Restructuring Plan.

Net income attributable to H.B. Fuller in the third quarter of 2017 was $25.1 million compared to $32.7 million in the third quarter of 2016. On a diluted earnings per share basis, the third quarter of 2017 was $0.49 per share compared to $0.64 per share for the third quarter of 2016.

Net income attributable to H.B. Fuller in the first nine months of 2017 was $65.8 million compared to $85.0 million in the first nine months of 2016. On a diluted earnings per share basis, the first nine months of 2017 was $1.28 per share compared to $1.66 per share for the first nine months of 2016.

Restructuring Plan

During the first quarter of 2017, we approved a restructuring plan (the “2017 Restructuring Plan”) related to organizational changes and other actions to optimize operations. In implementing the 2017 Restructuring Plan, we expect to incur pre-tax costs of approximately $20.0 million which includes severance and related employee costs and costs related to the optimization of production facilities, streamlining of processes, rationalization of product offerings and accelerated depreciation of long-lived assets. The 2017 Restructuring Plan was implemented in the first quarter of 2017 and is currently expected to be completed by mid-year of fiscal 2018. During the third quarter and nine months ended September 2, 2017, we recorded a pre-tax charge of $1.3 million and $17.1 million, respectively, related to the 2017 Restructuring Plan.

Royal Adhesives Acquisition

On September 2, 2017, we signed an agreement to purchase Royal Adhesives and Sealants (“Royal Adhesives”) for $1,575.0 million, subject to customary adjustments. Royal Adhesives, a manufacturer of high-value specialty adhesives and sealants, is a supplier of industrial adhesives in a diverse set of end markets, including aerospace, transportation, commercial roofing, insulating glass, solar, packaging and flooring applications and operates 19 manufacturing facilities in five countries. The acquisition is expected to expand our presence in North America, Europe and China and add new technology and packaging capabilities. The acquisition is expected to close during the fourth quarter of 2017.

We expect to incur approximately $20.0 million in transaction costs associated with the acquisition, which include advisory, legal, consulting and insurance costs. We have incurred approximately $4.8 million of the expected transaction costs as of September 2, 2017. The Stock Purchase Agreement contains certain limited termination rights for all parties, including, among others, the right to terminate if the transaction is not completed by March 2, 2018.  In certain specified circumstances, upon termination of the Stock Purchase Agreement by the seller, including a termination by the seller for our breach, we will be required to pay the seller a termination fee equal to $78.8 million. 

We currently intend to enter into a new $1,850.0 million senior secured syndicated term loan facility and issue additional $300.0 million unsecured public notes to finance the Royal Adhesives acquisition purchase price and related transaction expenses and refinance certain of our existing indebtedness. We expect to incur approximately $72.9 million in financing related costs, which include early termination fees, new debt issuance costs and costs related to securing bridge loan financing. Approximately $32.5 million of these costs will be capitalized. 

Results of Operations

Net revenue:

	Three Months Ended							Nine Months Ended
	September 2,		August 27,		2017 vs			September 2,		August 27,		2017 vs
($ in millions)	2017		2016		2016			2017		2016		2016
Net revenue	$	562.9	$	512.9		9.8	%	$	1,627.8	$	1,519.7		7.1	%

29

We review variances in net revenue in terms of changes related to sales volume, product pricing, sales mix, business acquisitions and changes in foreign currency exchange rates. The impact of sales volume, product pricing, sales mix and acquisitions are viewed as constant currency growth. The following table shows the net revenue variance analysis for the third quarter and first nine months of 2017 compared to the same periods in 2016:

	Three Months Ended September 2, 2017			Nine Months Ended September 2, 2017
	vs August 27, 2016			vs August 27, 2016
Constant currency growth		11.3	%		10.1	%
Currency		(1.5	%)		(3.0	%)
Total		9.8	%		7.1	%

Constant currency growth was a positive 11.3 percent in the third quarter of 2017 compared to the third quarter of 2016. The 11.3 percent constant currency growth in the third quarter of 2017 was driven by 17.9 percent growth in Engineering Adhesives, 16.7 percent growth in Americas Adhesives, 10.4 percent growth in Asia Pacific and 9.6 percent growth in EIMEA, offset by a 8.1 percent decrease in Construction Products. The negative 1.5 percent currency impact was primarily driven by the devaluation of the Egyptian pound, Turkish lira, Chinese renminbi and Argentinian peso.

Constant currency growth was a positive 10.1 percent in the first nine months of 2017 compared to the first nine months of 2016.  The 10.1 percent constant currency growth in the first nine months of 2017 was driven by 23.0 percent growth in Engineering Adhesives, 13.6 percent growth in Asia Pacific, 9.0 percent growth in EIMEA and 11.6 percent growth in Americas Adhesives, offset by a 6.6 percent decrease in Construction Products.  The negative 3.0 percent currency impact was primarily driven by the devaluation of the Egyptian pound, Turkish lira, Chinese renminbi, Euro and Mexican peso.

Cost of sales:

	Three Months Ended									Nine Months Ended
	September 2,			August 27,			2017 vs			September 2,			August 27,			2017 vs
($ in millions)	2017			2016			2016			2017			2016			2016
Raw materials	$	316.5		$	273.9			15.5	%	$	902.3		$	813.4			10.9	%
Other manufacturing costs		96.0			92.8			3.4	%		290.1			264.3			9.8	%
Cost of sales	$	412.5		$	366.7			12.5	%	$	1,192.4		$	1,077.7			10.6	%
Percent of net revenue		73.3	%		71.5	%					73.3	%		70.9	%

Cost of sales in the third quarter of 2017 compared to the third quarter of 2016 increased 180 basis points as a percentage of net revenue. Raw material cost as a percentage of net revenue increased 280 basis points in the third quarter of 2017 compared to the third quarter of 2016 primarily due to higher raw material costs. Other manufacturing costs as a percentage of net revenue decreased 100 basis points in the third quarter of 2017 compared to the third quarter of 2016 driven primarily by the impact of acquired businesses and the implementation of the 2017 Restructuring Plan.

Cost of sales in the first nine months of 2017 compared to the first nine months of 2016 increased 240 basis points as a percentage of net revenue. Raw material cost as a percentage of net revenue increased 190 basis points in the first nine months of 2017 compared to the first nine months of 2016 primarily due to higher raw material costs. Other manufacturing costs as a percentage of net revenue increased 50 basis points in the first nine months of 2017 compared to the first nine months of 2016.

Gross profit:

	Three Months Ended									Nine Months Ended
	September 2,			August 27,			2017 vs			September 2,			August 27,			2017 vs
($ in millions)	2017			2016			2016			2017			2016			2016
Gross profit	$	150.4		$	146.1			2.9	%	$	435.4		$	442.0			(1.5%	)
Percent of net revenue		26.7	%		28.5	%					26.7	%		29.1	%

Gross profit in the first thirdquarter of 2017 increased 2.9 percent and gross profit margin decreased 180 basis points compared to the thirdquarter of 2016. The decrease in gross profit margin was primarily due to higher raw material costs, the impact of acquired businesses and the implementation of the 2017 Restructuring Plan.

30

Gross profit in the nine months of 2017 decreased 1.5 percent and gross profit margin decreased 240 basis points compared to the first ninemonths of 2016. The decrease in gross profit margin was primarily due to higher raw material costs, the impact of acquired businesses and the implementation of the 2017 Restructuring Plan.

Selling, general and administrative (SG&A) expenses:

	Three Months Ended									Nine Months Ended
	September 2,			August 27,			2017 vs			September 2,			August 27,			2017 vs
($ in millions)	2017			2016			2016			2017			2016			2016
SG&A	$	110.2		$	97.7			12.8	%	$	325.9		$	301.1			8.2	%
Percent of net revenue		19.6	%		19.0	%					20.0	%		19.8	%

SG&A expenses for the third quarter of 2017 increased $12.5 million, or 12.8 percent, compared to the third quarter of 2016.  The increase is mainly due to the impact of acquired businesses, transaction costs related to potential acquisitions and higher variable compensation, partially offset by lower expenses related to general spending reductions and foreign currency exchange rate benefits on spending outside the U.S.

SG&A expenses for the first nine months of 2017 increased $24.8 million, or 8.2 percent, compared to the first nine months of 2016.  The increase is mainly due to the impact of acquired businesses, transaction costs related to potential acquisitions, higher variable compensation and the implementation of the 2017 Restructuring Plan, partially offset by lower expenses related to general spending reductions and foreign currency exchange rate benefits on spending outside the U.S.

We make SG&A expense plans at the beginning of each fiscal year and barring significant changes in business conditions or our outlook for the future, we maintain these spending plans for the entire year. Management routinely monitors our SG&A spending relative to these fiscal year plans for each operating segment and for the company overall. We feel it is important to maintain a consistent spending program in this area as many of the activities within the SG&A category such as the sales force, technology development, and customer service are critical elements of our business strategy.

Special charges, net:

	Three Months Ended							Nine Months Ended
	September 2,		August 27,			2017 vs		September 2,		August 27,			2017 vs
($ in millions)	2017		2016			2016		2017		2016			2016
Special charges, net	$	-	$	(2.8	)		NMP	$	-	$	(2.0	)		NMP

NMP = Non-meaningful percentage

The following table provides detail of special charges, net:

	Three Months Ended					Nine Months Ended
	September 2,		August 27,			September 2,		August 27,
($ in millions)	2017		2016			2017		2016
Acquisition and transformation related costs	$	-	$	0.1		$	-	$	0.2
Facility exit costs		-		(2.9	)		-		(2.4	)
Other related costs		-		-			-		0.2
Special charges, net	$	-	$	(2.8	)	$	-	$	(2.0	)

The integration of the industrial adhesives business we acquired in March 2012 involved a significant amount of restructuring and capital investment to optimize the new combined entity. In addition to this acquisition, we announced our intentions to take a series of actions in our existing EIMEA operating segment to improve the profitability and future growth prospects of this operating segment. We combined these two initiatives into a single project which we refer to as the “Business Integration Project”. During the third quarter and nine months ended August 27, 2016, we incurred special charges, net of $(2.8) million and $(2.0) million respectively, for costs related to the Business Integration Project. The Business Integration Project was substantially complete at the end of 2016.

31

Other income (expense), net:

	Three Months Ended							Nine Months Ended
	September 2,		August 27,			2017 vs		September 2,		August 27,			2017 vs
($ in millions)	2017		2016			2016		2017		2016			2016
Other income (expense), net	$	0.2	$	(1.0	)		NMP	$	0.7	$	(7.6	)		NMP

NMP = Non-meaningful percentage

Other income (expense), net in the third quarter of 2017 included $0.8 million of interest income and $0.2 million of net financing income offset by $0.8 million of currency transaction losses. Other income (expense), net in the third quarter of 2016 included $1.0 million of currency transaction and re-measurement losses and $0.2 million of net financing expense offset by $0.5 million of interest income.

Other income (expense), net in the first nine months of 2017 included $2.2 million of interest income and $0.3 million of net financing income offset by $1.8 million of currency transaction losses. Other income (expense), net in the first nine months of 2016 included $9.1 million of currency transaction and re-measurement losses offset by $1.5 million of interest income.

Interest expense:

	Three Months Ended							Nine Months Ended
	September 2,		August 27,		2017 vs			September 2,		August 27,		2017 vs
($ in millions)	2017		2016		2016			2017		2016		2016
Interest expense	$	8.1	$	6.8		19.0	%	$	24.6	$	19.7		24.9	%

Interest expense in the third quarter of 2017 compared to the third quarter of 2016 was higher due to U.S. debt balances at higher interest rates from the issuance of our 4.000% Notes, and higher LIBOR rates on floating rate debt held in the U.S. We capitalized $0.1 million of interest expense in the third quarter of 2017 compared to $0.2 million in the same period last year.

Interest expense in the first nine months of 2017 compared to the same period last year was higher due to higher U.S. debt balances at higher interest rates from the issuance of our 4.000% Notes and higher LIBOR rates on floating rate debt held in the U.S. In addition, and as a result of the issuance of our 4.000% Notes during the first nine months of 2017, we recorded $0.5 million of accelerated amortization of debt issuance costs related to debt facilities that were repaid with proceeds from the 4.000% Notes. We capitalized $0.2 million of interest expense in the first nine months of 2017 compared to $0.6 million in the same period last year.

Income taxes:

	Three Months Ended									Nine Months Ended
	September 2,			August 27,			2017 vs			September 2,			August 27,			2017 vs
($ in millions)	2017			2016			2016			2017			2016			2016
Income taxes	$	9.3		$	12.5			(26.0%	)	$	26.2		$	35.6			(26.4%	)
Effective tax rate		28.7	%		28.8	%					30.6	%		30.8	%

Income tax expense of $9.3 million in the third quarter of 2017 includes $0.2 million of discrete tax expense and $3.9 million of tax benefit from costs primarily related to the restructuring plans and other non-recurring items. Excluding the discrete tax expense and the effects of these items, the overall effective tax rate was 29.4 percent. 

Income tax expense of $26.2 million in the first nine months of 2017 includes $1.1 million of discrete tax expense and $9.8 million of tax benefit from costs primarily related to the restructuring plans and other non-recurring items. Excluding the discrete tax expense and the effects of these items, the overall effective tax rate was 29.4 percent.

32

Income from equity method investments:

	Three Months Ended							Nine Months Ended
	September 2,		August 27,		2017 vs			September 2,		August 27,		2017 vs
($ in millions)	2017		2016		2016			2017		2016		2016
Income from equity method investments	$	2.2	$	1.8		17.9	%	$	6.4	$	5.2		24.7	%

The income from equity method investments relates to our 50 percent ownership of the Sekisui-Fuller joint venture in Japan. The higher income for the third quarter and first nine months of 2017 compared to the same periods of 2016 relates to higher net income in our joint venture.

Net income attributable to non-controlling interests:

Net income attributable to non-controlling interests relates primarily to an 11 percent redeemable non-controlling interest in HBF Turkey and was not material for the quarter ended September 2, 2017 and August 27, 2016. During the first quarter of 2017, we purchased the remaining shares from the non-controlling shareholder.

Net income attributable to H.B. Fuller:

	Three Months Ended									Nine Months Ended
	September 2,			August 27,			2017 vs			September 2,			August 27,			2017 vs
($ in millions)	2017			2016			2016			2017			2016			2016
Net income attributable to H.B. Fuller	$	25.1		$	32.7			(23.2%	)	$	65.8		$	85.0			(22.6%	)
Percent of net revenue		4.5	%		6.4	%					4.0	%		5.6	%

The net income attributable to H.B. Fuller for the third quarter of 2017 was $25.1 million compared to $32.7 million for the third quarter of 2016. The diluted earnings per share for the third quarter of 2017 was $0.49 per share as compared to $0.64 per share for the third quarter of 2016.

The net income attributable to H.B. Fuller for the first nine months of 2017 was $65.8 million compared to $85.0 million for the first nine months of 2016. The diluted earnings per share for the first nine months of 2017 was $1.28 per share as compared to $1.66 per share for the first nine months of 2016.

Operating Segment Results

We have five reportable segments: Americas Adhesives, EIMEA (Europe, India, Middle East and Africa), Asia Pacific, Construction Products and Engineering Adhesives. Operating results of each of these segments are regularly reviewed by our chief operating decision maker to make decisions about resources to be allocated to the segments and assess their performance.

The tables below provide certain information regarding the net revenue and segment operating income of each of our operating segments. For segment evaluation by the chief operating decision maker, segment operating income is defined as gross profit less SG&A expenses. Segment operating income excludes special charges, net.

33

Net Revenue by Segment:

	Three Months Ended										Nine Months Ended
	September 2, 2017					August 27, 2016					September 2, 2017					August 27, 2016
	Net		% of			Net		% of			Net		% of			Net		% of
($ in millions)	Revenue		Total			Revenue		Total			Revenue		Total			Revenue		Total
Americas Adhesives	$	230.9		41	%	$	199.0		39	%	$	653.6		40	%	$	588.4		39	%
EIMEA		137.4		24	%		130.6		25	%		396.7		24	%		394.8		26	%
Asia Pacific		63.0		11	%		57.5		11	%		190.1		12	%		171.5		11	%
Construction Products		59.1		11	%		64.4		13	%		179.9		11	%		192.1		13	%
Engineering Adhesives		72.5		13	%		61.4		12	%		207.5		13	%		172.9		11	%
Total	$	562.9		100	%	$	512.9		100	%	$	1,627.8		100	%	$	1,519.7		100	%

Segment Operating Income (Loss):

	Three Months Ended											Nine Months Ended
	September 2, 2017						August 27, 2016					September 2, 2017						August 27, 2016
($ in millions)	Segment Operating Income  (Loss)			% of Total			Segment Operating Income		% of Total			Segment Operating Income (Loss)			% of Total			Segment Operating Income		% of Total
Americas Adhesives	$	26.7			66	%	$	31.9		67	%	$	74.1			67	%	$	94.0		67	%
EIMEA		9.9			25	%		8.4		17	%		19.8			18	%		25.6		18	%
Asia Pacific		2.8			7	%		2.5		5	%		9.5			9	%		9.3		6	%
Construction Products		1.0			3	%		2.1		4	%		(1.6	)		(1	%)		5.4		4	%
Engineering Adhesives		4.6			11	%		3.5		7	%		12.5			11	%		6.5		5	%
Corporate		(4.8	)		(12	%)		-		-			(4.8	)		(4	%)		-		-
Total	$	40.2			100	%	$	48.4		100	%	$	109.5			100	%	$	140.8		100	%

The following table provides a reconciliation of segment operating income to income before income taxes and income from equity method investments, as reported on the Condensed Consolidated Statements of Income:

	Three Months Ended						Nine Months Ended
	September 2,			August 27,			September 2,			August 27,
($ in millions)	2017			2016			2017			2016
Segment operating income	$	40.2		$	48.4		$	109.5		$	140.8
Special charges, net		-			2.8			-			2.0
Other income (expense), net		0.1			(1.0	)		0.7			(7.6	)
Interest expense		(8.1	)		(6.8	)		(24.6	)		(19.7	)
Income before income taxes and income from equity method investments	$	32.2		$	43.4		$	85.6		$	115.5

Americas Adhesives

	Three Months Ended									Nine Months Ended
	September 2,			August 27,			2017 vs			September 2,			August 27,			2017 vs
($ in millions)	2017			2016			2016			2017			2016			2016
Net revenue	$	230.9		$	199.0			16.0	%	$	653.6		$	588.4			11.1	%
Segment operating income	$	26.7		$	31.9			(16.3	%)	$	74.1		$	94.0			(21.2	%)
Segment operating margin		11.5	%		16.0	%					11.3	%		16.0	%

34

The following table provides details of the Americas Adhesives net revenue variances:

	Three Months Ended September 2, 2017			Nine Months Ended September 2, 2017
	vs August 27, 2016			vs August 27, 2016
Constant currency growth		16.7	%		11.6	%
Currency		(0.7	%)		(0.5	%)
Total		16.0	%		11.1	%

Net revenue increased 16.0 percent in the third quarter of 2017 compared to the third quarter of 2016.  The 16.7 percent increase in constant currency growth was attributable to a 16.9 percent increase in sales volume, including a 10.6 percent increase due to the Wisdom Adhesives acquisition, and a 0.2 percent increase in product pricing offset by an unfavorable 0.4 percent decrease in sales mix.  The 0.7 percent negative currency effect was due to the weaker Argentinian peso and Brazilian real, offset by the stronger Mexican peso compared to the U.S. dollar. As a percentage of net revenue, raw material costs increased 410 basis points mainly due to higher raw material costs. Other manufacturing costs as a percentage of net revenue increased 60 basis points, primarily due to the acquisition and integration of Wisdom Adhesives and volume increases. Segment operating income decreased 16.3 percent and segment operating margin as a percentage of net revenue decreased 450 basis points compared to the third quarter of 2016.

Net revenue increased 11.1 percent in the first nine months of 2017 compared to the first nine months of 2016.  The 11.6 percent increase in constant currency growth was attributable to a 13.5 percent increase in sales volume, including an 8.7 percent increase due to the Wisdom Adhesives acquisition, offset by a 1.1 percent decrease due to unfavorable sales mix and a 0.8 percent decrease in product pricing.  The 0.5 percent negative currency effect was due to the weaker Mexico peso and Argentinian peso, offset by the stronger Brazilian real and Colombian peso compared to the U.S. dollar. As a percentage of net revenue, raw material costs increased 340 basis points mainly due to lower sales prices and higher raw material costs, and the impact of valuing inventories related to the Wisdom Adhesives acquisition at fair value. Other manufacturing costs as a percentage of net revenue increased 130 basis points, primarily due to the acquisition and integration of Wisdom Adhesives and higher delivery expense.  Segment operating income decreased 21.2 percent and segment operating margin as a percentage of net revenue decreased 470 basis points compared to the first nine months of 2016.

EIMEA

	Three Months Ended									Nine Months Ended
	September 2,			August 27,			2017 vs			September 2,			August 27,			2017 vs
($ in millions)	2017			2016			2016			2017			2016			2016
Net revenue	$	137.4		$	130.6			5.2	%	$	396.7		$	394.8			0.5	%
Segment operating income	$	9.9		$	8.4			17.4	%	$	19.8		$	25.6			(22.8	%)
Segment operating margin		7.2	%		6.5	%					5.0	%		6.5	%

The following table provides details of the EIMEA net revenue variances:

	Three Months Ended September 2, 2017			Nine Months Ended September 2, 2017
	vs August 27, 2016			vs August 27, 2016
Constant currency growth		9.6	%		9.0	%
Currency		(4.4	%)		(8.5	%)
Total		5.2	%		0.5	%

Net revenue increased 5.2 percent in the third quarter of 2017 compared to the third quarter of 2016.  The 9.6 percent increase in constant currency growth was attributable to a 4.4 percent increase in sales volume, a 5.6 percent increase in product pricing and a 0.4 percent decrease in unfavorable sales mix.  The negative currency effect of 4.4 percent was primarily the result of a weaker Egyptian pound and Turkish lira offset by a stronger Euro compared to the U.S. dollar.  Sales volume growth was primarily related to the hygiene and durable assembly markets. In addition, we had strong growth in both core Europe and the emerging markets.  Raw material cost as a percentage of net revenue increased 210 basis points in the third quarter compared to the third quarter last year primarily due to higher raw material costs offset by higher product pricing.  Other manufacturing costs as a percentage of net revenue were 290 basis points lower than the third quarter of 2016 primarily due to improved cost control and higher sales volume.  Segment operating income increased 17.4 percent and segment operating margin increased 70 basis points compared to the third quarter of 2016.

35

Net revenue increased 0.5 percent in the first nine months of 2017 compared to the first nine months of 2016.  The 9.0 percent increase in constant currency growth was attributable to a 4.9 percent increase in sales volume and a 4.1 percent increase in product pricing.  The negative currency effect of 8.5 percent was primarily the result of a weaker Egyptian pound and Turkish lira offset by a stronger Euro compared to the U.S. dollar.  Sales volume growth was primarily related to the hygiene and durable assembly markets, and strong growth in the emerging markets.  Raw material cost as a percentage of net revenue increased 100 basis points in the nine months compared to the nine months last year primarily due to higher raw material costs offset by higher product pricing.  Other manufacturing costs as a percentage of net revenue were 40 basis points lower than the first nine months of 2016.  SG&A expenses as a percentage of net revenue increased 90 basis points due to higher variable compensation and the implementation of the 2017 Restructuring Plan.  Segment operating income decreased 22.8 percent and segment operating margin decreased 150 basis points compared to the first nine months of 2016.

Asia Pacific

	Three Months Ended									Nine Months Ended
	September 2,			August 27,			2017 vs			September 2,			August 27,			2017 vs
($ in millions)	2017			2016			2016			2017			2016			2016
Net revenue	$	63.0		$	57.5			9.5	%	$	190.1		$	171.5			10.9	%
Segment operating income	$	2.8		$	2.5			12.4	%	$	9.5		$	9.3			1.6	%
Segment operating margin		4.5	%		4.4	%					5.0	%		5.4	%

The following table provides details of the Asia Pacific net revenue variances:

	Three Months Ended September 2, 2017			Nine Months Ended September 2, 2017
	vs August 27, 2016			vs August 27, 2016
Constant currency growth		10.4	%		13.6	%
Currency		(0.9	%)		(2.7	%)
Total		9.5	%		10.9	%

Net revenue in the third quarter of 2017 increased 9.5 percent compared to the third quarter of 2016.  The 10.4 percent increase in constant currency growth was attributable to a 9.4 percent increase in sales volume, a 0.8 percent increase due to favorable sales mix and a 0.2 percent increase in product pricing.  Organic constant currency growth was primarily driven by volume growth in Greater China. Negative currency effects of 0.9 percent compared to the third quarter of 2016 were primarily driven by the weaker Chinese renminbi and Malaysian ringgit compared to the U.S. dollar partially offset by a stronger Australian dollar.  Raw material costs as a percentage of net revenue increased 250 basis points compared to the third quarter of 2016 primarily due to higher raw material costs.  Other manufacturing costs as a percentage of net revenue decreased 150 basis points compared to the third quarter of 2016 primarily due to higher sales volume.  SG&A expenses as a percentage of net revenue decreased 110 basis points due to higher revenue, general spending reductions and foreign currency exchange rate benefits on spending outside the U.S. Segment operating income increased 12.4 percent and segment operating margin increased 10 basis points compared to the third quarter of 2016. 

Net revenue in the first nine months of 2017 increased 10.9 percent compared to the first nine months of 2016.  The 13.6 percent increase in constant currency growth was attributable to a 15.4 percent increase in sales volume including a 3.9 percent increase due to the Advanced Adhesives acquisition, partially offset by a 0.8 percent decrease due to unfavorable sales mix and a 1.0 percent decrease in product pricing.  Organic constant currency growth was primarily driven by volume growth in Greater China. Negative currency effects of 2.7 percent compared to the first nine months of 2016 were primarily driven by the weaker Chinese renminbi and Malaysian ringgit compared to the U.S. dollar partially offset by a stronger Australian dollar.  Raw material costs as a percentage of net revenue increased 120 basis points compared to the first nine months of 2016 due to lower product pricing and higher raw material costs.  Other manufacturing costs as a percentage of net revenue decreased 40 basis points compared to the first nine months of 2016.  Segment operating income increased 1.6 percent and segment operating margin decreased 40 basis points compared to the first nine months of 2016. 

36

Construction Products

	Three Months Ended									Nine Months Ended
	September 2,			August 27,			2017 vs			September 2,			August 27,			2017 vs
($ in millions)	2017			2016			2016			2017			2016			2016
Net revenue	$	59.1		$	64.4			(8.3	%)	$	179.9		$	192.1			(6.4	%)
Segment operating income	$	1.0		$	2.1			(54.4	%)	$	(1.6	)	$	5.4			(129.2	%)
Segment operating margin		1.6	%		3.3	%					(0.9	%)		2.8	%

The following tables provide details of the Construction Products net revenue variances:

	Three Months Ended September 2, 2017			Nine Months Ended September 2, 2017
	vs August 27, 2016			vs August 27, 2016
Constant currency growth		(8.1%	)		(6.6	%)
Currency		(0.2%	)		0.2	%
Total		(8.3%	)		(6.4	%)

Net revenue decreased 8.3 percent in the third quarter of 2017 compared to the third quarter of 2016.  The 8.1 percent decrease in constant currency growth was driven by a 8.9 percent decrease in sales volume, slightly offset by a 0.6 percent increase due to favorable sales mix, and a 0.2 percent increase in product pricing. The negative currency effect was 0.2 percent. The sales volume decline was due to lower service levels related to the facility upgrade and expansion project and the impact of Hurricane Harvey, which occurred late in the third quarter of 2017.  Raw material cost as a percentage of net revenue was 60 basis points higher in the third quarter of 2017 compared to last year primarily due to higher raw material costs.  Other manufacturing costs as a percentage of net revenue were 10 basis points lower in the third quarter of 2017 compared to the third quarter of 2016. SG&A expenses as a percentage of net revenue increased 120 basis points due to lower revenue.  Segment operating income decreased 54.4 percent and segment operating margin decreased 170 basis points compared to the third quarter of 2016.

Net revenue decreased 6.4 percent in the first nine months of 2017 compared to the first nine months of 2016.  The 6.6 percent decrease in constant currency growth was driven by a 6.3 percent decrease in sales volume, a 0.2 percent decrease due to unfavorable sales mix, and a 0.1 percent decrease in product pricing. The positive currency effect was 0.2 percent. The sales volume decline was due to lower service levels related to the facility upgrade and expansion project and the impact of Hurricane Harvey, which occurred late in the third quarter of 2017.  Raw material cost as a percentage of net revenue was 100 basis points lower in the first nine months of 2017 compared to the first nine months of 2016 primarily due to favorable product mix and lower raw material costs.  Other manufacturing costs as a percentage of net revenue were 410 basis points higher in the first nine months of 2017 compared to the first nine months of 2016 due to the discontinuance of certain retail and wholesale products in connection with the implementation of the 2017 Restructuring Plan and inefficiencies related to the facility upgrade and expansion project. SG&A expenses as a percentage of net revenue increased 60 basis points due to lower revenue. Segment operating income decreased 129.2 percent and segment operating margin decreased 370 basis points compared to the first nine months of 2016.

Engineering Adhesives

	Three Months Ended									Nine Months Ended
	September 2,			August 27,			2017 vs			September 2,			August 27,			2017 vs
($ in millions)	2017			2016			2016			2017			2016			2016
Net revenue	$	72.5		$	61.4			18.1	%	$	207.5		$	172.9			20.0	%
Segment operating income	$	4.6		$	3.5			31.3	%	$	12.5		$	6.5			93.0	%
Segment operating margin		6.3	%		5.7	%					6.0	%		3.7	%

37

The following tables provide details of the Engineering Adhesives net revenue variances:

	Three Months Ended September 2, 2017			Nine Months Ended September 2, 2017
	vs August 27, 2016			vs August 27, 2016
Constant currency growth		17.9	%		23.0	%
Currency		0.2	%		(3.0	%)
Total		18.1	%		20.0	%

Net revenue increased 18.1 percent in the third quarter of 2017 compared to the third quarter of 2016.  The 17.9 percent increase in constant currency growth was attributable to a 19.0 percent increase in sales volume including a 0.7 percent increase due to the acquisition of Cyberbond, partially offset by a 1.1 percent decrease due to unfavorable sales mix.  Organic constant currency growth was driven by strong performance in the electronics and Tonsan markets.  Positive currency effects of 0.2 percent compared to the third quarter of last year were primarily driven by the weaker Chinese renminbi compared to the U.S. dollar.  Raw material cost as a percentage of net revenue was 110 basis points higher in the third quarter of 2017 compared to the third quarter of 2016 due to unfavorable sales mix and higher raw material costs. Other manufacturing costs as a percentage of net revenue were 130 basis points lower in the third quarter of 2017 compared to the third quarter of 2016 due to higher sales volume.  Segment operating income increased 31.3 percent and segment operating margin increased 60 basis points compared to the third quarter of 2016.

Net revenue increased 20.0 percent in the first nine months of 2017 compared to the first nine months of 2016.  The 23.0 percent increase in constant currency growth was attributable to a 25.3 percent increase in sales volume including a 4.5 percent increase due to the acquisition of Cyberbond, partially offset by a 1.9 percent decrease in product pricing and a 0.4 percent decrease due to unfavorable sales mix.  Organic constant currency growth was driven by strong performance in the automotive, electronics and Tonsan markets.  Negative currency effects of 3.0 percent compared to the first nine months of last year were primarily driven by the weaker Chinese renminbi compared to the U.S. dollar.  Raw material cost as a percentage of net revenue was 130 basis points higher in the first nine months of 2017 compared to the first nine months of 2016 due to lower product prices and higher raw material costs. Other manufacturing costs as a percentage of net revenue were 110 basis points lower in the first nine months of 2017 compared to the first nine months of 2016 due to higher sales volume.  SG&A expenses as a percentage of net revenue decreased 250 basis points due to higher revenue and the mark to market adjustment related to the Tonsan contingent consideration liability offset by higher variable compensation.  Segment operating income increased 93.0 percent and segment operating margin increased 230 basis points compared to the first nine months of 2016.

Financial Condition, Liquidity and Capital Resources

Total cash and cash equivalents as of September 2, 2017 were $119.6 million compared to $142.2 million as of December 3, 2016 and $133.1 million as of August 27, 2016. The majority of the $119.6 million in cash and cash equivalents as of September 2, 2017 was held outside the United States. Total long and short-term debt was $799.0 million as of September 2, 2017, $703.3 million as of December 3, 2016 and $709.0 million as of August 27, 2016. The total debt to total capital ratio as measured by Total Debt divided by (Total Debt plus Total Stockholders’ Equity) was 43.6 percent as of September 2, 2017 as compared to 42.8 percent as of December 3, 2016 and 42.6 percent as of August 27, 2016.

On September 2, 2017, we signed an agreement to purchase Royal Adhesives for $1,575.0 million.  We currently intend to enter into a new $1,850.0 million senior secured syndicated term loan facility and issue additional $300.0 million unsecured public notes to finance the Royal Adhesives acquisition purchase price and related transaction expenses and refinance certain of our existing indebtedness. We believe our cash flows from operating activities combined with the above financing plan will be adequate to meet our ongoing liquidity and capital expenditure needsfor the foreseeable future.

Cash available in the United States has historically been sufficient and we expect it will continue to be sufficient to fund U.S. operations and U.S. capital spending and U.S. pension and other postretirement benefit contributions in addition to funding U.S. dividend payments, debt service and share repurchases as needed.  For those international earnings considered to be reinvested indefinitely, we currently have no intention to, and plans do not indicate a need to, repatriate these funds for U.S. operations.

38

Our credit agreements and note purchase agreements include restrictive covenants that, if not met, could lead to a renegotiation of our credit lines and a significant increase in our cost of financing. At September 2, 2017, we were in compliance with all covenants of our contractual obligations as shown in the following table:

Covenant	Debt Instrument	Measurement	Result as of September 2, 2017
TTM EBITDA / TTM Interest Expense	All Debt Instruments	Not less than 2.5	7.8
Total Indebtedness / TTM EBITDA	All Debt Instruments	Not greater than 3.5	3.1

● TTM = Trailing 12 months

● EBITDA for covenant purposes is defined as consolidated net income, plus interest expense, taxes, depreciation and amortization, non-cash impairment losses, extraordinary non-cash losses incurred other than in the ordinary course of business, nonrecurring extraordinary non-cash restructuring charges, minus extraordinary non-cash gains incurred other than in the ordinary course of business. For the Total Indebtedness / TTM EBITDA ratio, TTM EBITDA is adjusted for the pro forma results from Material Acquisitions and Material Divestitures as if the acquisition or divestiture occurred at the beginning of the calculation period. Additional detail is provided in the Form 8-K dated April 12, 2017.

We believe we have the ability to meet all of our contractual obligations and commitments in fiscal 2017.

Selected Metrics of Liquidity

Key metrics we monitor are net working capital as a percent of annualized net revenue, trade accounts receivable days sales outstanding (“DSO”), inventory days on hand, free cash flow and debt capitalization ratio.

	September 2,			August 27,
	2017			2016
Net working capital as a percentage of annualized net revenue1		23.0	%		21.7	%
Accounts receivable DSO2	62 Days				60
Inventory days on hand3	73 Days				67
Free cash flow4	$	13.2		$	75.8
Total debt to total capital ratio5		43.6	%		42.6	%

¹ Current quarter net working capital (trade receivables, net of allowance for doubtful accounts plus inventory minus trade payables) divided by annualized net revenue (current quarter multiplied by four).

² Trade receivables net of the allowance for doubtful accounts at the balance sheet date multiplied by 56 (8 weeks) and divided by the net revenue for the last 2 months of the quarter.

³ Total inventory multiplied by 56 and divided by cost of sales (excluding delivery costs) for the last 2 months of the quarter.

⁴ Year-to-date net cash provided by operating activities, less purchased property, plant and equipment and dividends paid.

⁵ Total debt divided by (total debt plus total stockholders’ equity).

Summary of Cash Flows

Cash Flows from Operating Activities:

	Nine Months Ended
	September 2,		August 27,
($ in millions)	2017		2016
Net cash provided by operating activities	$	70.8	$	145.9

39

Net income including non-controlling interests was $65.8 million in the first nine months of 2017 compared to $85.2 million in the first nine months of 2016. Depreciation and amortization expense totaled $59.5 million in the first nine months of 2017 compared to $57.2 million in the first nine months of 2016. Accrued compensation was a source of cash of $3.9 million in 2017 compared to a use of cash of $6.7 million last year related to higher accruals for our employee incentive plans. Other accrued expenses was a use of cash of $5.8 million in the nine months ending September 2, 2017 compared to a $4.9 million use of cash in same period last year. Other liabilities was a source of cash of $12.6 million in the first nine months of 2017 compared to a use of cash of $9.1 million in the first nine months of 2016.

Changes in net working capital (trade receivables, inventory and trade payables) accounted for a use of cash of $46.3 million compared to a source of cash of $18.0 million last year. The table below provides the cash flow impact due to changes in the components of net working capital:

	Nine Months Ended
	September 2,			August 27,
($ in millions)	2017			2016
Trade receivables, net	$	(14.0	)	$	25.6
Inventory		(55.3	)		(6.2	)
Trade payables		23.0			(1.4	)
Total cash flow impact	$	(46.3	)	$	18.0

● Trade Receivables, net – Trade Receivables, net was a use of cash of $14.0 million in 2017 compared to a source of cash of $25.6 million in 2016. The use of cash in 2017 compared to source of cash in 2016 was due to an increase in trade receivables in the current year compared to the prior year. The DSO were 62 days at September 2, 2017 and 60 days at August 27, 2016.

● Inventory – Inventory was a use of cash of $55.3 million and $6.2 million in 2017 and 2016, respectively. The higher use of cash in 2017 is due to higher raw material costs and increasing inventory levels to maintain service levels while integrating our Wisdom acquisition. The lower use of cash in 2016 is related to lower seasonal build of inventory in 2016. Inventory days on hand were 73 days as of September 2, 2017 and 67 days as of August 27, 2016.

● Trade Payables – For the first nine months of 2017 trade payables was a source of cash of $23.0 million compared to a use of cash of $1.4 million in 2016. The use of cash in 2016 compared to the source of cash in 2017 is primarily related to higher purchases of inventory somewhat offset by lower purchases of property, plant and equipment.

Cash Flows from Investing Activities:

	Nine Months Ended
	September 2,			August 27,
($ in millions)	2017			2016
Net cash used in investing activities	$	(159.3	)	$	(96.5	)

In the first quarter of 2017, we acquired Wisdom Adhesives for $123.3 million. Purchases of property, plant and equipment were $35.5 million during the nine months ended September 2, 2017 as compared to $49.6 million for the same period of 2016.

Cash Flows from Financing Activities:

	Nine Months Ended
	September 2,		August 27,
($ in millions)	2017		2016
Net cash provided by (used in) financing activities	$	61.2	$	(31.5	)

We had $643.0 million of proceeds from the issuance of long-term debt in the nine months ended September 2, 2017 which consisted of $300.0 million of proceeds from the issuance of the 4.000% Notes, $100 million of proceeds from our refinanced term loan and $243.0 million of proceeds from our revolving credit facility. Proceeds from our revolving credit facility were drawn in conjunction with the acquisition of Wisdom Adhesives and from borrowing from ongoing operations. Repayments of long-term debt were $536.8 million in the nine months ended September 2, 2017 and $16.9 million in the nine months ended August 27, 2016. We also paid $3.8 million in debt issuance costs associated with the issuance of the 4.000% Notes in the first nine months of 2017. Net payments of notes payable were $10.9 million in 2017 compared to net proceeds of $6.6 million in 2016. Cash dividends paid were $22.1 million in 2017 compared to $20.6 million in 2016. Repurchases of common stock were $21.7 million in the nine months ended September 2, 2017 compared to $11.9 million in the same period of 2016.

40

Forward-Looking Statements and Risk Factors

The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements. In this Quarterly Report on Form 10-Q, we discuss expectations regarding our future performance which include anticipated financial performance, savings from restructuring and process initiatives, global economic conditions, liquidity requirements, the impact of litigation and environmental matters, the effect of new accounting pronouncements and one-time accounting charges and credits, and similar matters. This Quarterly Report on Form 10-Q contains forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of words like "plan," "expect," "aim," "believe," "project," "anticipate," "intend," "estimate," "will," "should," "could" (including the negative or variations thereof) and other expressions that indicate future events and trends. These plans and expectations are based upon certain underlying assumptions, including those mentioned with the specific statements. Such assumptions are in turn based upon internal estimates and analyses of current market conditions and trends, our plans and strategies, economic conditions and other factors. These plans and expectations and the assumptions underlying them are necessarily subject to risks and uncertainties inherent in projecting future conditions and results. Actual results could differ materially from expectations expressed in the forward-looking statements if one or more of the underlying assumptions and expectations proves to be inaccurate or is unrealized. In addition to the factors described in this report, Part II, Item 1A. Risk Factors in this report and Part I, Item 1A. Risk Factors in our Annual Report on Form 10-K for the fiscal year ended December 3, 2016, identify some of the important factors that could cause our actual results to differ materially from those in any such forward-looking statements. This list of important factors does not include all such factors nor necessarily present them in order of importance. In order to comply with the terms of the safe harbor, we have identified these important factors which could affect our financial performance and could cause our actual results for future periods to differ materially from the anticipated results or other expectations expressed in the forward-looking statements. Additionally, the variety of products sold by us and the regions where we do business makes it difficult to determine with certainty the increases or decreases in revenues resulting from changes in the volume of products sold, currency impact, changes in geographic and product mix and selling prices. Our best estimates of these changes as well as changes in other factors have been included. References to volume changes include volume, product mix and delivery charges, combined. These factors should be considered, together with any similar risk factors or other cautionary language, which may be made elsewhere in this Quarterly Report on Form 10-Q.

We may refer to Part II, Item 1A. Risk Factors and this section of the Form 10-Q to identify risk factors related to other forward looking statements made in oral presentations, including investor conferences and/or webcasts open to the public.

This disclosure, including that under "Forward-Looking Statements and Risk Factors," and other forward-looking statements and related disclosures made by us in this report and elsewhere from time to time, represents our best judgment as of the date the information is given. We do not undertake responsibility for updating any of such information, whether as a result of new information, future events, or otherwise, except as required by law. Investors are advised, however, to consult any further public company disclosures (such as in filings with the Securities and Exchange Commission or in company press releases) on related subjects.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

Market Risk

We are exposed to various market risks, including changes in interest rates, foreign currency rates and prices of raw materials. Market risk is the potential loss arising from adverse changes in market rates and prices, such as interest rates and foreign currency exchange rates.

Our financial performance may be negatively affected by unfavorable economic conditions.  Recessionary economic conditions may have an adverse impact on our sales volumes, pricing levels and profitability.  As domestic and international economic conditions change, trends in discretionary consumer spending also become unpredictable and subject to reductions due to uncertainties about the future.  A general reduction in consumer discretionary spending due to recessionary conditions in the domestic and international economies, or uncertainties regarding future economic prospects, could have a material adverse effect on our results of operations.

41

Interest Rate Risk

Exposure to changes in interest rates result primarily from borrowing activities used to fund operations and acquisitions.  Committed floating rate credit facilities are used to fund a portion of operations.  We believe that probable near-term changes in interest rates would not materially affect financial condition, results of operations or cash flows.  The annual impact on interest expense of a one-percentage point interest rate change on the outstanding balance of our variable rate debt as of September 2, 2017 would have resulted in a change in net income of approximately $8.1 million or $0.16 per diluted share.

Foreign Exchange Risk

As a result of being a global enterprise, there is exposure to market risks from changes in foreign currency exchange rates. Our operating results and financial condition are subject to both currency transaction and currency translation risk. Approximately 57 percent of net revenue was generated outside of the United States for the third quarter of 2017. Principal foreign currency exposures relate to the Euro, British pound sterling, Canadian dollar, Chinese renminbi, Japanese yen, Australian dollar, Argentine peso, Brazilian real, Colombian peso, Mexican peso, Turkish lira, Egyptian pound, Indian rupee, Indonesian rupiah and Malaysian ringgit.

We enter into cross border transactions through importing and exporting goods to and from different countries and locations. These transactions generate foreign exchange risk as they create assets, liabilities and cash flows in currencies other than their functional currency. This also applies to services provided and other cross border agreements among subsidiaries. Our objective is to balance, where possible, non-functional currency denominated assets to non-functional currency denominated liabilities to have a natural hedge and minimize foreign exchange impacts.

In the event a natural hedge is not available, we take steps to minimize risks from foreign currency exchange rate fluctuations through normal operating and financing activities and, when deemed appropriate, through the use of derivative instruments. We do not enter into any speculative positions with regard to derivative instruments.

Based on financial results for the nine months ended September 2, 2017, a hypothetical one percent change in our cost of sales due to foreign currency rate changes would have resulted in a change in net income attributable to H.B. Fuller of approximately $4.4 million or $0.09 per diluted share. Based on financial results for the nine months ended September 2, 2017 and foreign currency balance sheet positions as of September 2, 2017, a hypothetical overall 10 percent change in the U.S. dollar would have resulted in a change in net income of approximately $6.3 million or $0.12 per diluted share.

On December 4, 2016, for our subsidiaries in Latin America, we changed the functional currency from the U.S. dollar to the entity’s local currency based on management’s analysis of the changes of the economic facts and circumstances in which these subsidiaries operate. The change in functional currency is accounted for prospectively from December 4, 2016 and financial statements prior to and including the year ended December 3, 2016 have not been restated for the change in functional currency.

Raw Materials

The principal raw materials used to manufacture products include resins, polymers, synthetic rubbers, vinyl acetate monomer and plasticizers. We generally avoid sole source supplier arrangements for raw materials. While alternate supplies of most key raw materials are available, unplanned supplier production outages may lead to strained supply-demand situations for several key raw materials such as ethylene and propylene, several polymers and other petroleum derivatives such as waxes.

The purchase of raw materials is our largest expenditure. Our objective is to purchase raw materials that meet both our quality standards and production needs at the lowest total cost. Most raw materials are purchased on the open market or under contracts that limit the frequency but not the magnitude of price increases. In some cases, however, the risk of raw material price changes is managed by strategic sourcing agreements which limit price increases to increases in supplier feedstock costs, while requiring decreases as feedstock costs decline. The leverage of having substitute raw materials approved for use wherever possible is used to minimize the impact of possible price increases. Based on financial results for the nine months ended September 2, 2017, a hypothetical one percent change in our raw material costs would have resulted in a change in net income of approximately $6.3 million or $0.12 per diluted share.

42

Item 4. Controls and Procedures

Controls and Procedures

We conducted an evaluation, under the supervision and with the participation of our president and chief executive officer and executive vice president, chief financial officer, of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (Exchange Act)) as of September 2, 2017.  We acquired Wisdom Adhesives in the first quarter of 2017, which represented approximately six percent of our total assets as of September 2, 2017. As this acquisition occurred in the first quarter of 2017, the scope of our assessment of the effectiveness of internal control over financial reporting does not include this recent acquisition. This exclusion is in accordance with the SEC’s general guidance that an assessment of a recently acquired business may be omitted from our scope in the year of acquisition. Based on this evaluation, our president and chief executive officer and executive vice president, chief financial officer concluded that, as of September 2, 2017, our disclosure controls and procedures were effective.

For purposes of Rule 13a-15(e), the term disclosure controls and procedures means controls and other procedures of an issuer that are designed to ensure that information required to be disclosed by the issuer in the reports that it files or submits under the Exchange Act (15 U.S.C. 78a et seq.) is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer’s management, including its president and chief executive officer and executive vice president, chief financial officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting during our most recently completed fiscal quarter that have materially affected or are reasonably likely to materially affect our internal control over financial reporting, as defined in Rule 13a-15(f) under the Exchange Act.

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

Environmental Matters

From time to time, we become aware of compliance matters relating to, or receive notices from, federal, state or local entities regarding possible or alleged violations of environmental, health or safety laws and regulations. We review the circumstances of each individual site, considering the number of parties involved, the level of potential liability or our contribution relative to the other parties, the nature and magnitude of the hazardous substances involved, the method and extent of remediation, the estimated legal and consulting expense with respect to each site and the time period over which any costs would likely be incurred. Also, from time to time, we are identified as a potentially responsible party (“PRP”) under the Comprehensive Environmental Response, Compensation and Liability Act and/or similar state laws that impose liability for costs relating to the clean up of contamination resulting from past spills, disposal or other release of hazardous substances. We are also subject to similar laws in some of the countries where current and former facilities are located. Our environmental, health and safety department monitors compliance with applicable laws on a global basis. To the extent we can reasonably estimate the amount of our probable liabilities for environmental matters, we establish a financial provision.

Currently we are involved in various environmental investigations, clean up activities and administrative proceedings and lawsuits. In particular, we are currently deemed a PRP in conjunction with numerous other parties, in a number of government enforcement actions associated with landfills and/or hazardous waste sites. As a PRP, we may be required to pay a share of the costs of investigation and clean up of these sites. In addition, we are engaged in environmental remediation and monitoring efforts at a number of current and former operating facilities. While uncertainties exist with respect to the amounts and timing of the ultimate environmental liabilities, based on currently available information, we have concluded that these matters, individually or in the aggregate, will not have a material adverse effect on our results of operations, financial condition or cash flow. However, adverse developments and/or periodic settlements could negatively impact the results of operations or cash flows in one or more future periods.

43

Other Legal Proceedings

From time to time and in the ordinary course of business, we are a party to, or a target of, lawsuits, claims, investigations and proceedings, including product liability, personal injury, contract, patent and intellectual property, environmental, health and safety, tax and employment matters. While we are unable to predict the outcome of these matters, we have concluded, based upon currently available information, that the ultimate resolution of any pending matter, individually or in the aggregate, including the asbestos litigation described in the following paragraphs, will not have a material adverse effect on our results of operations, financial condition or cash flow.

We have been named as a defendant in lawsuits in which plaintiffs have alleged injury due to products containing asbestos manufactured more than 30 years ago. The plaintiffs generally bring these lawsuits against multiple defendants and seek damages (both actual and punitive) in very large amounts. In many cases, plaintiffs are unable to demonstrate that they have suffered any compensable injuries or that the injuries suffered were the result of exposure to products manufactured by us. We are typically dismissed as a defendant in such cases without payment. If the plaintiff presents evidence indicating that compensable injury occurred as a result of exposure to our products, the case is generally settled for an amount that reflects the seriousness of the injury, the length, intensity and character of exposure to products containing asbestos, the number and solvency of other defendants in the case, and the jurisdiction in which the case has been brought.

A significant portion of the defense costs and settlements in asbestos-related litigation is paid by third parties, including indemnification pursuant to the provisions of a 1976 agreement under which we acquired a business from a third party. Currently, this third party is defending and paying settlement amounts, under a reservation of rights, in most of the asbestos cases tendered to the third party.

In addition to the indemnification arrangements with third parties, we have insurance policies that generally provide coverage for asbestos liabilities, including defense costs. Historically, insurers have paid a significant portion of our defense costs and settlements in asbestos-related litigation. However, certain of our insurers are insolvent. We have entered into cost-sharing agreements with our insurers that provide for the allocation of defense costs and settlements and judgments in asbestos-related lawsuits. These agreements require, among other things, that we fund a share of settlements and judgments allocable to years in which the responsible insurer is insolvent.

A summary of the number of and settlement amounts for asbestos-related lawsuits and claims is as follows:

	Nine Months Ended				3 Years Ended
($ in millions)	September 2, 2017		August 27, 2016		December 3, 2016
Lawsuits and claims settled		7		9		33
Settlement amounts	$	1.6	$	1.0	$	3.1
Insurance payments received or expected to be received	$	1.3	$	0.6	$	2.3

We do not believe that it would be meaningful to disclose the aggregate number of asbestos-related lawsuits filed against us because relatively few of these lawsuits are known to involve exposure to asbestos-containing products that we manufactured. Rather, we believe it is more meaningful to disclose the number of lawsuits that are settled and result in a payment to the plaintiff. To the extent we can reasonably estimate the amount of our probable liabilities for pending asbestos-related claims, we establish a financial provision and a corresponding receivable for insurance recoveries. 

Based on currently available information, we have concluded that the resolution of any pending matter, including asbestos-related litigation, individually or in the aggregate, will not have a material adverse effect on our results of operations, financial condition or cash flow. However, adverse developments and/or periodic settlements could negatively impact the results of operations or cash flows in one or more future periods.

Item 1A. Risk Factors

This Form 10-Q contains forward-looking statements concerning our future programs, products, expenses, revenue, liquidity and cash needs as well as our plans and strategies. These forward-looking statements are based on current expectations and we assume no obligation to update this information. Numerous factors could cause actual results to differ significantly from the results described in these forward-looking statements, including the risk factors identified under Part I, Item 1A. Risk Factors contained in our Annual Report on Form 10-K for the fiscal year ended December 3, 2016. There have been no material changes in the risk factors disclosed by us under Part I, Item 1A. Risk Factors contained in the Annual Report on Form 10-K for the fiscal year ended December 3, 2016, except as follows with respect to our proposed acquisition of ASP Royal Acquisition Corp. (“Royal Adhesives”) pursuant to the Stock Purchase Agreement, dated September 2, 2017, as disclosed in our Current Report on Form 8-K filed with the SEC on September 5, 2017 (the “Royal Adhesives acquisition”):

44

Risks Related to the Royal Adhesives Acquisition

We may not realize the revenue growth opportunities and cost synergies that are anticipated from the planned Royal Adhesives acquisition as we may experience difficulties in integrating Royal Adhesives’ business with ours.

The benefits that are expected to result from the Royal Adhesives acquisition will depend, in part, on our ability to realize the anticipated revenue growth opportunities and cost synergies as a result of the planned acquisition. Our success in realizing these revenue growth opportunities and cost synergies, and the timing of this realization, depends on the successful integration of Royal Adhesives. There is a significant degree of difficulty and management distraction inherent in the process of integrating an acquisition as sizable as Royal Adhesives. The process of integrating operations could cause an interruption of, or loss of momentum in, our and Royal Adhesives’ activities. Members of our senior management may be required to devote considerable amounts of time to this integration process, which will decrease the time they will have to manage our company, service existing customers, attract new customers and develop new products or strategies. If senior management is not able to effectively manage the integration process, or if any significant business activities are interrupted as a result of the integration process, our business could suffer. There can be no assurance that we will successfully or cost-effectively integrate Royal Adhesives. The failure to do so could have a material adverse effect on our business, financial condition or results of operations.

Even if we are able to integrate Royal Adhesives successfully, this integration may not result in the realization of the full benefits of the growth opportunities and cost synergies that we currently expect from this integration, and we cannot guarantee that these benefits will be achieved within anticipated timeframes or at all. For example, we may not be able to eliminate duplicative costs. Moreover, we may incur substantial expenses in connection with the integration of Royal Adhesives. While it is anticipated that certain expenses will be incurred to achieve cost synergies, such expenses are difficult to estimate accurately, and may exceed current estimates. Accordingly, the benefits from the planned acquisition may be offset by costs incurred to, or delays in, integrating the businesses.

If our financing for the Royal Adhesives acquisition becomes unavailable, the acquisition may not be completed.

We intend to finance the acquisition with new debt financing. On September 2, 2017, we entered into the bridge commitment letter with Morgan Stanley, providing us commitments with respect to financing to be utilized in connection with funding the Royal Adhesives acquisition. In the event that the financing contemplated by the bridge commitment letter is not available, is available in less than the full amount or is available in a manner that requires us to utilize the bridge term facility, necessary financing for the Royal Adhesives acquisition may not be available on acceptable terms, in a timely manner or at all. The closing of the Royal Adhesives acquisition is not conditioned on our ability to obtain financing. However, if alternative financing becomes necessary and we are unable to secure such alternative financing, we may not be able to complete the Royal Adhesives acquisition and may be required to pay the seller a $78.75 million termination fee.

We and Royal Adhesives may be unable to obtain the regulatory approvals required to complete the Royal Adhesives acquisition.

Completion of the Royal Adhesives acquisition is conditioned upon, among other conditions, the expiration or termination of any waiting period under the Hart-Scott-Rodino Act and the receipt of antitrust approval in Germany. We and Royal Adhesives are pursuing all required consents, orders and approvals in accordance with the Royal Adhesives stock purchase agreement. These consents, orders and approvals may impose conditions on or require divestitures relating to our or Royal Adhesives’ divisions, operations or assets, or may impose requirements, limitations or costs or place restrictions on the conduct of the combined company’s business. The Royal Adhesive stock purchase agreement requires us and Royal Adhesives, among other things, to accept all such conditions, divestitures, requirements, limitations, costs or restrictions that may be imposed by regulatory entities. Such conditions, divestitures, requirements, limitations, costs or restrictions may jeopardize or delay completion of the Royal Adhesives acquisition, may reduce the anticipated benefits of the Royal Adhesives acquisition or may result in the abandonment of the Royal Adhesives acquisition. Further, no assurance can be given that the required consents, orders and approvals will be obtained or that the required conditions to closing will be satisfied, and, even if all such consents, orders and approvals are obtained and such conditions are satisfied, no assurance can be given as to the terms, conditions and timing of such consents, orders and approvals.

The announcement and pendency of the Royal Adhesives acquisition could impact or cause disruptions in our and Royal Adhesives’ businesses which could have an adverse effect on our business, financial condition or results of operations following the completion of the Royal Adhesives acquisition.

The announcement and pendency of the Royal Adhesives acquisition could cause disruption in our and Royal Adhesives’ businesses, including:

● our and Royal Adhesives’ current and prospective customers and suppliers may experience uncertainty associated with the Royal Adhesives acquisition, including with respect to current or future business relationships with us, Royal Adhesives or the combined company and may attempt to negotiate changes in existing business;

● our and Royal Adhesives’ employees may experience uncertainty about their future roles with us, which may adversely affect our and Royal Adhesives’ ability to retain and hire key employees;

● the Royal Adhesives acquisition may give rise to potential liabilities; and

● the attention of our management and that of Royal Adhesives may be directed toward the completion and implementation of the Royal Adhesives acquisition and transaction-related considerations and may be diverted from the day-to-day business operations of the respective companies.

In connection with the Royal Adhesives acquisition, we could also encounter additional transaction and integration-related costs or other factors such as the failure to realize all of the benefits anticipated in the Royal Adhesives acquisition, as described in more detail above. The disruption to Royal Adhesives’ business could be exacerbated by a delay in the completion of the Royal Adhesives acquisition.

The debt we expect to incur in connection with the Royal Adhesives acquisition could have a negative impact on our liquidity or restrict our activities.

If the Royal Adhesives acquisition is consummated, we expect that our outstanding indebtedness will significantly increase as a result. Our current indebtedness and this new debt financing contain or will contain various covenants that limit our ability to engage in specified types of transactions. Our overall leverage and the terms of our financing arrangements could:

● limit our ability to obtain additional financing in the future for working capital, capital expenditures and acquisitions;

45

● make it more difficult to satisfy our obligations under the terms of our indebtedness;

● limit our ability to refinance our indebtedness on terms acceptable to us or at all;

● limit our flexibility to plan for and adjust to changing business and market conditions in the industries in which we operate and increase our vulnerability to general adverse economic and industry conditions;

● require us to dedicate a substantial portion of our cash flow to make interest and principal payments on our debt, thereby limiting the availability of our cash flow to fund future acquisitions, working capital, business activities, and other general corporate requirements;

● limit our ability to obtain additional financing for working capital, to fund growth or for general corporate purposes, even when necessary to maintain adequate liquidity, particularly if any ratings assigned to our debt securities by rating organizations were revised downward; and

● subject us to higher levels of indebtedness than our competitors, which may cause a competitive disadvantage and may reduce our flexibility in responding to increased competition.

In addition, the restrictive covenants would require us to maintain specified financial ratios and satisfy other financial condition tests. Our ability to meet those financial ratios and tests will depend on our ongoing financial and operating performance, which, in turn, will be subject to economic conditions and to financial, market, and competitive factors, many of which are beyond our control. A breach of any of these covenants could result in a default under the instruments governing our indebtedness.

Royal Adhesives may have liabilities that are not known, probable or estimable at this time.

As a result of the Royal Adhesives acquisition, Royal Adhesives will become our subsidiary and it will remain subject to all of its liabilities. There could be unasserted claims or assessments that we failed or were unable to discover or identify in the course of performing due diligence investigations of Royal Adhesives. In addition, there may be liabilities that are neither probable nor estimable at this time that may become probable or estimable in the future. Any such liabilities, individually or in the aggregate, could have a material adverse effect on our financial results. We may learn additional information about Royal Adhesives that adversely affects us, such as unknown, unasserted or contingent liabilities and issues relating to compliance with applicable laws.

Without limitation to the generality of the foregoing, Royal Adhesives is subject to various rules, regulations, laws and other legal requirements, enforced by governments or other public authorities. Misconduct, fraud, non-compliance with applicable laws and regulations, or other improper activities by any of Royal Adhesives’ directors, officers, employees or agents could have a significant impact on Royal Adhesives’ business and reputation and could subject Royal Adhesives to fines and penalties, criminal, civil and administrative legal sanctions and suspension from contracting (including with public bodies), resulting in reduced revenues and profits. Such misconduct could include the failure to comply with regulations prohibiting bribery, regulations on lobbying or similar activities, control over financial reporting, environmental laws and any other applicable laws or regulations.

Upon completion of the Royal Adhesives acquisition, we may become subject to additional risks and uncertainties relating to Royal Adhesives and its business.

Following the Royal Adhesives acquisition, we will be subject to additional risks associated with Royal Adhesives, which could have a material adverse effect on our business, financial condition, results of operations and cash flows. The integration process may be complex, costly and time-consuming, as Royal Adhesives is not currently operating as a public company. The difficulties of integrating the businesses include, among others:

● failure to implement our business plan for the combined company;

● unanticipated issues in integrating equipment, logistics, information, communications and other systems;

● possible inconsistencies in standards, controls, contracts, procedures and policies;

● impacts of change in control provisions in contracts and agreements;

● failure to retain key customers and suppliers;

● unanticipated changes in applicable laws and regulations;

● failure to recruit and retain key employees to operate the combined business;

● increased competition within the industries in which Royal Adhesives operates;

● inherent operating risks in the business;

● unanticipated issues, expenses and liabilities;

● additional reporting requirements pursuant to applicable rules and regulations;

● additional requirements relating to internal control over financial reporting; and

● unfamiliarity with operating in many of the countries in which Royal Adhesives currently operates.

46

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Issuer Purchases of Equity Securities

Information on our purchases of equity securities during the third quarter ended September 2, 2017 follows:

Period	(a) Total Number of Shares Purchased1		(b) Average Price Paid per Share		(c) Total Number of Shares Purchased as Part of a Publicly Announced Plan or Program		(d) Maximum Approximate Dollar Value of Shares that may yet be Purchased Under the Plan or Program (millions)
June 4, 2017 - July 8, 2017		125,000	$	51.41		125,000	$	193,573
July 9, 2017 - August 5, 2017		125,000	$	51.22		125,000	$	187,170
August 6, 2017 - September 2, 2017		287	$	51.35		-	$	187,170

¹ The total number of shares purchased include shares withheld to satisfy the employees’ withholding taxes upon vesting of restricted stock.

Repurchases of common stock are made to support our stock-based employee compensation plans and for other corporate purposes. Upon vesting of restricted stock awarded to employees, shares are withheld to cover the employees’ minimum withholding taxes.

On April 6, 2017, the Board of Directors authorized a new share repurchase program of up to $200.0 million of our outstanding common shares. Under the program, we are authorized to repurchase shares for cash on the open market, from time to time, in privately negotiated transactions or block transactions, or through an accelerated repurchase agreement. The timing of such repurchases is dependent on price, market conditions and applicable regulatory requirements. Upon repurchase of the shares, we reduced our common stock for the par value of the shares with the excess being applied against additional paid-in capital. This authorization replaces the September 30, 2010 authorization to repurchase shares.

47

Item 6. Exhibits

2.1 Stock Purchase Agreement, dated as of September 2, 2017, by and among H.B. Fuller Company, HBF Windsor Holding Co., ASP Royal Acquisition Corp., and ASP Royal Holdings LLC (incorporated by reference to Exhibit 2.1 in H.B. Fuller’s Current Report on Form 8-K filed on September 5, 2017)

10.1 Commitment Letter, dated as of September 2, 2017, by and among H.B. Fuller Company and Morgan Stanley Senior Funding, Inc. (incorporated by reference to Exhibit 10.1 in H.B. Fuller’s Current Report on Form 8-K filed on September 5, 2017)

31.1 Form of 302 Certification –James J. Owens

31.2 Form of 302 Certification –John J. Corkrean

32.1 Form of 906 Certification –James J. Owens

32.2 Form of 906 Certification –John J. Corkrean

101 The following materials from the H.B. Fuller Company Quarterly Report on Form 10-Q for the quarter ended September 2, 2017 formatted in Extensible Business Reporting Language (XBRL): (i) the Condensed Consolidated Statements of Income, (ii) the Condensed Consolidated Statements of Comprehensive Income, (iii) the Condensed Consolidated Balance Sheets, (iv) the Condensed Consolidated Statements of Total Equity, (v) the Condensed Consolidated Statements of Cash Flows and (vi) the Notes to Condensed Consolidated Financial Statements.

48

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

H.B. Fuller Company

Dated: September 29, 2017	/s/ John J. Corkrean
	John J. Corkrean
	Executive Vice President,
	Chief Financial Officer

49

Exhibit Index

Exhibits

2.1 Stock Purchase Agreement, dated as of September 2, 2017, by and among H.B. Fuller Company, HBF Windsor Holding Co., ASP Royal Acquisition Corp., and ASP Royal Holdings LLC (incorporated by reference to Exhibit 2.1 in H.B. Fuller’s Current Report on Form 8-K filed on September 5, 2017)

10.1 Commitment Letter, dated as of September 2, 2017, by and among H.B. Fuller Company and Morgan Stanley Senior Funding, Inc. (incorporated by reference to Exhibit 10.1 in H.B. Fuller’s Current Report on Form 8-K filed on September 5, 2017)

31.1 Form of 302 Certification – James J. Owens

31.2 Form of 302 Certification – John J. Corkrean

32.1 Form of 906 Certification –James J. Owens

32.2 Form of 906 Certification –John J. Corkrean

101 The following materials from the H.B. Fuller Company Quarterly Report on Form 10-Q for the quarter ended September 2, 2017 formatted in Extensible Business Reporting Language (XBRL): (i) the Condensed Consolidated Statements of Income, (ii) the Condensed Consolidated Statements of Comprehensive Income, (iii) the Condensed Consolidated Balance Sheets, (iv) the Condensed Consolidated Statements of Total Equity, (v) the Condensed Consolidated Statements of Cash Flows and (vi) the Notes to Condensed Consolidated Financial Statements.

50